{"meta":{"query_hash":"4a4253388019","filters":{"venue":"Expert Opinion on Therapeutic Targets"},"cohort_total":89,"direct_labels_cover":1,"predictions_cover":89,"exported":89,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4a4253388019","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Opinion+on+Therapeutic+Targets"},"results":[{"id":"W1965301111","doi":"10.1517/14728222.2011.537656","title":"The promise and challenges of targeting RSK for the treatment of cancer","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Serine; Threonine; Protein-Serine-Threonine Kinases; Biology; Phosphorylation; Cancer; Cancer research; Ribosomal s6 kinase; Cell biology; Genetics; Protein kinase A; Protein kinase B","score_opus":0.03705129146068916,"score_gpt":0.315687583912151,"score_spread":0.2786362924514619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965301111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011075668,0.8701546,0.007837494,0.09535402,0.0037023397,0.000063792766,0.00018729079,0.00023091269,0.011393878],"genre_scores_gemma":[0.06686207,0.8885329,0.00819131,0.018623302,0.008026505,0.00016908326,0.0002700531,0.000059881713,0.009264973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950373,0.00014977848,0.00003607493,0.000069559464,0.00013950534,0.00010127795],"domain_scores_gemma":[0.9993617,0.00028979045,0.000059756836,0.000045136003,0.00015152855,0.000092010814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003011941,0.0007435516,0.0016587015,0.00054421584,0.00049864425,0.0017540376,0.00108071,0.0026248007,0.0051956913],"category_scores_gemma":[0.0012337074,0.00022976114,0.00091315917,0.00038494254,0.0014099039,0.0033344738,0.0007851278,0.0046686647,0.0030312552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018855041,0.00050246075,0.0012110783,0.003880491,0.00029486808,0.0014651979,0.00023999448,0.003245353,0.048372183,0.039196815,0.09874678,0.8009592],"study_design_scores_gemma":[0.0008573178,0.002453142,0.0026122702,0.0011178398,0.00029956066,0.004553667,0.00069859554,0.0038561332,0.0140677905,0.067017026,0.9023269,0.00013986403],"about_ca_topic_score_codex":0.00053828006,"about_ca_topic_score_gemma":0.001712295,"teacher_disagreement_score":0.0051956913,"about_ca_system_score_codex":0.00083610625,"about_ca_system_score_gemma":0.001178053,"threshold_uncertainty_score":0.01738125},"labels":[],"label_agreement":null},{"id":"W1965676778","doi":"10.1517/14728220802600715","title":"PCSK9 as a therapeutic target of dyslipidemia","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Dyslipidemia; Proprotein convertase; Medicine; Pharmacology; Internal medicine; Cholesterol; Disease; LDL receptor; Lipoprotein","score_opus":0.07195171311946463,"score_gpt":0.38167704167601885,"score_spread":0.3097253285565542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965676778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006624914,0.99530184,0.00041625812,0.00076698716,0.00044559044,0.000010464054,0.000016947022,0.000020443844,0.0023588992],"genre_scores_gemma":[0.0037687588,0.99117094,0.00069756166,0.00072132976,0.0004909612,0.000021397827,0.0000716556,0.0000034692755,0.0030539033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990857,0.000015567324,0.000008553856,0.000015341757,0.0000391195,0.000012874211],"domain_scores_gemma":[0.99991155,0.000027571718,0.000013332671,0.000002683696,0.00002961686,0.00001529514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035677856,0.00068063603,0.00090306206,0.0009650398,0.00018298984,0.00046123285,0.0005638013,0.0011132,0.0033390042],"category_scores_gemma":[0.00021689845,0.00014407153,0.00028212712,0.0007669971,0.00027338834,0.0006970675,0.00027000895,0.0013776998,0.0024931782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021260863,0.00014143607,0.00018043256,0.0058924784,0.000078866135,0.00057741615,0.000039154547,0.0004557071,0.010583521,0.0029990242,0.030334948,0.9485045],"study_design_scores_gemma":[0.00014408358,0.0003893809,0.0014337437,0.0015801406,0.0001306491,0.0037260316,0.000050801475,0.0003362418,0.003753027,0.0023358664,0.9860973,0.000022683844],"about_ca_topic_score_codex":0.0004701519,"about_ca_topic_score_gemma":0.0009826383,"teacher_disagreement_score":0.0033390042,"about_ca_system_score_codex":0.0004785727,"about_ca_system_score_gemma":0.000558312,"threshold_uncertainty_score":0.01117003},"labels":[],"label_agreement":null},{"id":"W1970143948","doi":"10.1517/14728222.12.3.327","title":"Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Urotensin-II; Endothelin receptor; Pathogenesis; Pathophysiology; Vasodilation; Receptor; Medicine; Internal medicine; Pharmacology; Endothelin 1; Endocrinology","score_opus":0.09739691803559454,"score_gpt":0.36964368708675666,"score_spread":0.27224676905116213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970143948","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002476735,0.99625814,0.00028622634,0.0015935764,0.00041993897,0.000007981112,0.000019919344,0.000014445035,0.0011521201],"genre_scores_gemma":[0.001264598,0.9955771,0.000593546,0.0010201675,0.000473037,0.000017850152,0.000036866324,0.000002942761,0.0010138878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998246,0.000042209605,0.000021238115,0.000027810655,0.00006421519,0.000020008923],"domain_scores_gemma":[0.9997873,0.00008080292,0.00003412502,0.000007857869,0.00006105883,0.000028999033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006286438,0.00063633645,0.0019348346,0.0008518922,0.00027401568,0.0007722051,0.0010645752,0.0014061815,0.0045189043],"category_scores_gemma":[0.0005124168,0.00018699568,0.00040105355,0.00083912036,0.00049225456,0.0014072312,0.0003826423,0.0018979079,0.003670993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021707448,0.00013430498,0.00015993376,0.012803934,0.00010283536,0.00051586074,0.000088343346,0.00035306398,0.008599628,0.0043873806,0.050551094,0.9220865],"study_design_scores_gemma":[0.00013061863,0.00036862903,0.0007797208,0.0029869906,0.00013482134,0.0024693625,0.00013657095,0.0001647506,0.0010215291,0.004225252,0.98755264,0.00002916606],"about_ca_topic_score_codex":0.00046868314,"about_ca_topic_score_gemma":0.0013492261,"teacher_disagreement_score":0.0045189043,"about_ca_system_score_codex":0.00048335237,"about_ca_system_score_gemma":0.00069555984,"threshold_uncertainty_score":0.015117228},"labels":[],"label_agreement":null},{"id":"W1971264300","doi":"10.1517/14728222.12.3.313","title":"CD4<sup>+</sup>CD25<sup>+</sup>regulatory T cells: a therapeutic target for liver diseases","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Immune system; Immunology; Immunity; IL-2 receptor; Regulatory T cell; Homeostasis; FOXP3; Peripheral tolerance; Disease; Biology; Immune tolerance; Medicine; Cancer research; T cell; Cell biology; Internal medicine","score_opus":0.06504250241665019,"score_gpt":0.3380372406764606,"score_spread":0.27299473825981047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971264300","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036435566,0.99607086,0.00039362273,0.0007887413,0.0005036826,0.000008499389,0.00001881194,0.00001523773,0.0018361561],"genre_scores_gemma":[0.0019904345,0.99430853,0.00073756994,0.0005152418,0.00049733627,0.000014770563,0.000039546892,0.0000025564689,0.001894069],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998578,0.000028825516,0.000018245784,0.000018773837,0.00005871702,0.000017650806],"domain_scores_gemma":[0.9998549,0.000045311033,0.000029313007,0.000004320075,0.000048100635,0.000017922355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044320745,0.000625852,0.0011630728,0.0013015047,0.00018549597,0.00076095155,0.00068790495,0.0012053209,0.0046918923],"category_scores_gemma":[0.00037962353,0.00015557314,0.00035035744,0.0012671876,0.0002702397,0.0010535216,0.00027998214,0.0008793536,0.0034471278],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013490755,0.00006491214,0.00015388642,0.013714774,0.00008187208,0.00054779573,0.000043696138,0.00028516463,0.011056064,0.0021326165,0.03052096,0.9412634],"study_design_scores_gemma":[0.000061859835,0.00022474627,0.0010415319,0.004422608,0.00021782948,0.0041722474,0.00010927582,0.00022250976,0.003841021,0.0029272297,0.98273486,0.00002435252],"about_ca_topic_score_codex":0.0004606981,"about_ca_topic_score_gemma":0.0007758367,"teacher_disagreement_score":0.0046918923,"about_ca_system_score_codex":0.00041630378,"about_ca_system_score_gemma":0.0008526593,"threshold_uncertainty_score":0.01569599},"labels":[],"label_agreement":null},{"id":"W1973606269","doi":"10.1517/14728220903531454","title":"Targeting DAX-1 in embryonic stem cells and cancer","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Institute of Cancer Research; Institut National Du Cancer; Ministerio de Ciencia e Innovación; Fundación Científica Asociación Española Contra el Cáncer; Agence Nationale de la Recherche","keywords":"Embryonic stem cell; Stem cell; Biology; Neuroscience; Transcription factor; Nuclear receptor; Cancer; Drug discovery; Cancer stem cell; Drug development; Cancer cell; Bioinformatics; Cancer research; Cell biology; Drug; Pharmacology; Genetics; Gene","score_opus":0.03857099482044137,"score_gpt":0.34537274292948394,"score_spread":0.3068017481090426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973606269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022929073,0.99586403,0.00034164477,0.00072287756,0.000551523,0.000010153655,0.000026093623,0.000015466538,0.002238862],"genre_scores_gemma":[0.0007219793,0.99626935,0.00036474105,0.00037307825,0.00022076211,0.000009800076,0.000040150164,0.000002478613,0.0019975947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999882,0.000017871958,0.000013820301,0.000018166202,0.000056433928,0.000011793982],"domain_scores_gemma":[0.9998938,0.00003177005,0.000016423746,0.000004573751,0.00003710366,0.000016383292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043406925,0.00067159714,0.0009348231,0.0010774364,0.00022744875,0.0006618431,0.00071033253,0.0010599958,0.0032814795],"category_scores_gemma":[0.0002901794,0.00021941506,0.00027795677,0.0011172098,0.00032473105,0.0010134605,0.0005443147,0.0014752903,0.004101923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007251389,0.000056057477,0.00012000549,0.008324517,0.000047423975,0.0004343011,0.00006190806,0.0004826048,0.009087624,0.005625159,0.06751531,0.90817255],"study_design_scores_gemma":[0.000013479622,0.000046232057,0.000295132,0.0009682184,0.000024802634,0.0011551926,0.000029390554,0.00007291498,0.00087407493,0.0014901108,0.9950211,0.000009361465],"about_ca_topic_score_codex":0.00094696606,"about_ca_topic_score_gemma":0.0019111872,"teacher_disagreement_score":0.0032814795,"about_ca_system_score_codex":0.0007301247,"about_ca_system_score_gemma":0.0006700934,"threshold_uncertainty_score":0.010977626},"labels":[],"label_agreement":null},{"id":"W1978308081","doi":"10.1517/14728222.2011.638626","title":"Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Insulin-like growth factor 1 receptor; Insulin receptor; Insulin-Like Growth Factor Receptor; Signal transduction; Insulin-like growth factor; Cancer; Carcinogenesis; Growth factor receptor; Receptor; Biology; Cancer research; Growth factor; Medicine; Insulin resistance; Insulin; Internal medicine; Endocrinology; Cell biology","score_opus":0.1186887029938829,"score_gpt":0.36218737222166775,"score_spread":0.24349866922778485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978308081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009656095,0.99737847,0.00018890559,0.0004462296,0.0003188352,0.00000764138,0.0000216466,0.00001117821,0.001530571],"genre_scores_gemma":[0.00055278296,0.9976286,0.00028641731,0.00028561728,0.0001642098,0.000008694389,0.00003769183,0.00000190755,0.0010340062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998336,0.000025923107,0.000016798751,0.000027481812,0.00008008483,0.000016039985],"domain_scores_gemma":[0.9998267,0.00006368261,0.000030194464,0.000004980393,0.000058064306,0.000016493277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004569246,0.0008986091,0.0010808454,0.0016510835,0.00019643123,0.0006428864,0.00077649165,0.0010380237,0.005150851],"category_scores_gemma":[0.0004452952,0.00018871305,0.00049409806,0.001742477,0.0003325193,0.0009709556,0.0005221825,0.0019526045,0.0044191377],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006617301,0.00006957076,0.000067758985,0.011344077,0.00007003327,0.00016717863,0.00002965743,0.0003638263,0.002540887,0.0026512544,0.04837623,0.9342533],"study_design_scores_gemma":[0.000024889843,0.00007171061,0.00038596033,0.0026672797,0.00007435527,0.0010011656,0.000030935404,0.00010895475,0.000530085,0.0012850371,0.99380577,0.000013905833],"about_ca_topic_score_codex":0.0009208227,"about_ca_topic_score_gemma":0.0019284886,"teacher_disagreement_score":0.005150851,"about_ca_system_score_codex":0.00067948987,"about_ca_system_score_gemma":0.0008075178,"threshold_uncertainty_score":0.017231345},"labels":[],"label_agreement":null},{"id":"W1980561165","doi":"10.1517/14728222.2014.941285","title":"Long noncoding RNAs in liver cancer: what we know in 2014","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Epigenetics; Hepatocellular carcinoma; In silico; Biology; Non-coding RNA; Bioinformatics; Long non-coding RNA; microRNA; Cancer; Liver cancer; Gene; Computational biology; Medicine; RNA; Cancer research; Genetics","score_opus":0.04810450334453387,"score_gpt":0.3857445742934832,"score_spread":0.3376400709489493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980561165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000103514045,0.9961422,0.00012400262,0.0016736635,0.0010376455,0.000005899045,0.000040650033,0.000009601705,0.00086284615],"genre_scores_gemma":[0.00047126538,0.9973037,0.00017228525,0.00083645666,0.000597376,0.0000057366174,0.000051550935,0.0000018754215,0.00055983657],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977,0.00003863185,0.00004114779,0.000040403753,0.00008156242,0.000028321054],"domain_scores_gemma":[0.99928373,0.0002585545,0.00009057673,0.000016028811,0.0002596172,0.00009159156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008046251,0.00076956645,0.0013159654,0.0018026412,0.00037206974,0.0012043833,0.0007937877,0.0015709515,0.0052943863],"category_scores_gemma":[0.0012230445,0.000322865,0.0006353932,0.0021078174,0.00050707266,0.0021359397,0.0009966955,0.0022352203,0.0028513544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009852179,0.00003593603,0.00028019285,0.018140048,0.000093221286,0.00020338812,0.00007888278,0.00020745676,0.00128507,0.0023848757,0.063956186,0.91323614],"study_design_scores_gemma":[0.000013007322,0.00008522502,0.00089507556,0.0063381116,0.00013289377,0.0010088079,0.00009442011,0.000087447836,0.00033924967,0.0015435203,0.9894371,0.000025026286],"about_ca_topic_score_codex":0.0012901317,"about_ca_topic_score_gemma":0.0021275177,"teacher_disagreement_score":0.0052943863,"about_ca_system_score_codex":0.0008304529,"about_ca_system_score_gemma":0.0019294636,"threshold_uncertainty_score":0.01771146},"labels":[],"label_agreement":null},{"id":"W1982661637","doi":"10.1517/14728222.9.5.901","title":"Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University; NOSM University; University of Alberta","funders":"","keywords":"Syk; Immunology; Tyrosine kinase; Immune system; Medicine; Inflammation; Cancer research; Signal transduction; Biology; Cell biology","score_opus":0.0501508995772739,"score_gpt":0.331019571064058,"score_spread":0.28086867148678407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982661637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007197549,0.9952494,0.00040153836,0.0006883638,0.0006906396,0.000012158833,0.000018166507,0.000015640342,0.0022043728],"genre_scores_gemma":[0.0032032398,0.9904484,0.0007021434,0.00083167886,0.0007131044,0.000019877318,0.00007439751,0.000002791923,0.004004336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988306,0.000018302608,0.0000123455675,0.000020251762,0.000051526677,0.000014431711],"domain_scores_gemma":[0.9999362,0.000015759362,0.000013209375,0.000002094045,0.0000186064,0.000014114482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004167163,0.0008075952,0.001079542,0.0009935313,0.00022166438,0.00054459827,0.0007146928,0.0012801272,0.0032967941],"category_scores_gemma":[0.00018138367,0.00017336536,0.0003376033,0.0007663099,0.00033408107,0.0009679068,0.00034838283,0.0013776112,0.002910747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023838169,0.0001595171,0.0001916419,0.008308561,0.00009607401,0.0014031997,0.0000749432,0.00045289687,0.0205079,0.0040100836,0.041541472,0.9230154],"study_design_scores_gemma":[0.00011888114,0.00041427047,0.0010859515,0.0008970602,0.000097610624,0.0039784154,0.000068458976,0.00020306912,0.0027114877,0.0019044777,0.9884991,0.00002124183],"about_ca_topic_score_codex":0.0004786067,"about_ca_topic_score_gemma":0.0017906142,"teacher_disagreement_score":0.0032967941,"about_ca_system_score_codex":0.0005460849,"about_ca_system_score_gemma":0.0005663494,"threshold_uncertainty_score":0.011028886},"labels":[],"label_agreement":null},{"id":"W1984861197","doi":"10.1517/14728222.9.4.699","title":"The ERK/MAPK pathway, as a target for the treatment of neuropathic pain","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"","keywords":"MAPK/ERK pathway; Neuropathic pain; Peripheral nerve injury; Microglia; Medicine; Phosphorylation; Nerve injury; Protein kinase A; Kinase; Neuroscience; Extracellular; Cell biology; Pharmacology; Anesthesia; Internal medicine; Biology; Sciatic nerve; Inflammation","score_opus":0.08987020680163343,"score_gpt":0.3887323774116298,"score_spread":0.29886217060999637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984861197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025696447,0.995398,0.00037736533,0.0005608939,0.00048872066,0.00001772179,0.000029676687,0.000015845162,0.0028548613],"genre_scores_gemma":[0.0010134123,0.995336,0.00065138255,0.00035605786,0.0002887894,0.000020101053,0.00006235986,0.0000025531674,0.0022694855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984694,0.000026081616,0.0000144470805,0.000027753065,0.00006714395,0.000017664137],"domain_scores_gemma":[0.99988425,0.000027199048,0.00001898334,0.000004324983,0.000045621346,0.000019575387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000611409,0.0012897403,0.0016425772,0.00161208,0.00031687584,0.0008637934,0.0010771804,0.0013622118,0.006501537],"category_scores_gemma":[0.0002605839,0.00023379007,0.00043978004,0.0017959217,0.00043149636,0.001309557,0.00055123284,0.0017599192,0.007021228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018028705,0.00019126137,0.000088854424,0.012897302,0.000086400025,0.0004941427,0.00004749879,0.00043938754,0.009056477,0.0034046136,0.041554157,0.9315596],"study_design_scores_gemma":[0.00009784017,0.00027257332,0.00059669063,0.0015902731,0.000106772095,0.001571127,0.000059574304,0.00016127719,0.001706044,0.0023201623,0.9914921,0.000025641657],"about_ca_topic_score_codex":0.00074280694,"about_ca_topic_score_gemma":0.0017291674,"teacher_disagreement_score":0.006501537,"about_ca_system_score_codex":0.00063358963,"about_ca_system_score_gemma":0.00077829993,"threshold_uncertainty_score":0.021749794},"labels":[],"label_agreement":null},{"id":"W1985861853","doi":"10.1517/14728220802600707","title":"Regulation of the Na<sup>+</sup>/H<sup>+</sup>exchanger in the healthy and diseased myocardium","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Sodium–hydrogen antiporter; Extracellular; Intracellular; Ischemia; Gene isoform; Intracellular pH; Muscle hypertrophy; Cell biology; MAPK/ERK pathway; Chemistry; Kinase; Homeostasis; Phosphorylation; Reperfusion injury; Sodium-calcium exchanger; Internal medicine; Biochemistry; Biology; Endocrinology; Sodium; Medicine","score_opus":0.03546406584183281,"score_gpt":0.30733429336878293,"score_spread":0.2718702275269501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985861853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049363443,0.99738795,0.00033781698,0.000642539,0.00024930664,0.0000041420326,0.000014495964,0.0000109162165,0.0008592368],"genre_scores_gemma":[0.0019091801,0.9963953,0.0003732712,0.00027270635,0.00022709042,0.000007863149,0.000026833779,0.0000013640448,0.0007865232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988294,0.000022280336,0.00001460202,0.00002184635,0.00004527537,0.000012980248],"domain_scores_gemma":[0.99987423,0.00003290782,0.000028336977,0.0000038385715,0.000045876735,0.000014714032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037726242,0.00066028134,0.0012105394,0.00077592686,0.00016370835,0.0005569376,0.0007667793,0.0011820107,0.0020075715],"category_scores_gemma":[0.00029491298,0.00015080693,0.0002775783,0.0009632972,0.0003023879,0.0011171247,0.0003085554,0.0007823261,0.0018602923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025271619,0.000083630024,0.00034769496,0.017062096,0.000107769854,0.0006929243,0.00006881233,0.00078880676,0.024354212,0.0036125625,0.02731171,0.92531717],"study_design_scores_gemma":[0.00008860849,0.00041493087,0.004056812,0.0038011307,0.00028790746,0.0049959538,0.00019759023,0.0006298146,0.008440882,0.006506681,0.97052705,0.000052701907],"about_ca_topic_score_codex":0.0005347555,"about_ca_topic_score_gemma":0.0008645567,"teacher_disagreement_score":0.0020075715,"about_ca_system_score_codex":0.0004778149,"about_ca_system_score_gemma":0.00073006283,"threshold_uncertainty_score":0.006716013},"labels":[],"label_agreement":null},{"id":"W1988592217","doi":"10.1517/14728222.5.5.557","title":"Cyclin-dependent kinases and stroke","year":2001,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Stroke Network; Heart and Stroke Foundation of Canada","keywords":"Cyclin-dependent kinase; Kinase; Cyclin; Cell cycle; Cell biology; Stroke (engine); Programmed cell death; Biology; Neuroscience; Cancer research; Cell; Apoptosis; Biochemistry","score_opus":0.0312990668304086,"score_gpt":0.31307199963943433,"score_spread":0.2817729328090257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988592217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003021979,0.9798607,0.00033913183,0.005015948,0.0007720571,0.000011908899,0.000057126694,0.0000143703,0.01090668],"genre_scores_gemma":[0.021948006,0.964039,0.0004037152,0.0015449737,0.0009300055,0.000016884438,0.00011679286,0.0000035824603,0.010996929],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999087,0.000019091669,0.000007921443,0.00001729892,0.000030369612,0.00001664013],"domain_scores_gemma":[0.9999094,0.000021226571,0.000020464815,0.0000034850866,0.000022747541,0.000022591754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018074145,0.00036047798,0.000589543,0.0004417018,0.00029672787,0.0008656696,0.00027529933,0.0009816707,0.0054130736],"category_scores_gemma":[0.0002819623,0.000082531624,0.00018134149,0.00067647407,0.00030420293,0.0004583234,0.0003333932,0.00094416604,0.001445841],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006127648,0.00022064602,0.002295412,0.003295643,0.000120672856,0.0025316402,0.00020869776,0.00060627016,0.011724286,0.039080173,0.09684384,0.8424598],"study_design_scores_gemma":[0.0000744466,0.00028798194,0.009252324,0.0011088217,0.00008952731,0.0072267484,0.00023841985,0.00021120589,0.0039684223,0.02435396,0.95316434,0.000023801258],"about_ca_topic_score_codex":0.0019456133,"about_ca_topic_score_gemma":0.0033865436,"teacher_disagreement_score":0.0054130736,"about_ca_system_score_codex":0.00071742275,"about_ca_system_score_gemma":0.001034409,"threshold_uncertainty_score":0.018108547},"labels":[],"label_agreement":null},{"id":"W1988923285","doi":"10.1517/14728222.2014.988707","title":"Targeting microglia for the treatment of Alzheimer’s disease","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Microglia; Disease; Medicine; Biomarker; Immunology; Alzheimer's disease; Amyloid (mycology); Inflammation; Neuroscience; Clinical trial; Biology; Pathology","score_opus":0.1191297713207406,"score_gpt":0.42381129557605635,"score_spread":0.30468152425531575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988923285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012907457,0.99745876,0.00013776444,0.0005224037,0.00035509543,0.000010698294,0.000021671416,0.000010764573,0.0013537791],"genre_scores_gemma":[0.00077556423,0.99775887,0.00017486513,0.0003037001,0.00018408471,0.000009328376,0.000030778316,0.0000015434205,0.00076129887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977535,0.000039333565,0.000020209065,0.000030376948,0.00011070957,0.000024005589],"domain_scores_gemma":[0.9998429,0.000044530865,0.00003127275,0.0000043852083,0.000059189308,0.000017717124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051559904,0.0007850395,0.0011547492,0.0016240963,0.00021699586,0.0006854812,0.00073482847,0.0012310786,0.0051157335],"category_scores_gemma":[0.00045611066,0.00019292856,0.00059395604,0.0010176484,0.00037352543,0.00086087035,0.0005179133,0.001880099,0.0037008738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091247835,0.000095110045,0.00007518688,0.019689362,0.00011401314,0.00017833729,0.000058744205,0.0003240006,0.004592053,0.0036684806,0.057447072,0.9136663],"study_design_scores_gemma":[0.000039517872,0.00011577039,0.00037807334,0.0039554033,0.00010253197,0.0007522325,0.00003402897,0.00009376848,0.00074371306,0.0017315329,0.99203753,0.000015861384],"about_ca_topic_score_codex":0.00096590264,"about_ca_topic_score_gemma":0.0020174435,"teacher_disagreement_score":0.0051157335,"about_ca_system_score_codex":0.0005428619,"about_ca_system_score_gemma":0.00069735124,"threshold_uncertainty_score":0.017113864},"labels":[],"label_agreement":null},{"id":"W1998819602","doi":"10.1517/14728220903460340","title":"Targeting focal adhesion kinase signaling in tumor growth and metastasis","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Focal adhesion; Cancer research; Integrin; Signal transduction; Context (archaeology); Metastasis; Extracellular matrix; Cell biology; Cancer; Biology; Cell; Biochemistry","score_opus":0.07669444610687942,"score_gpt":0.3870655295582903,"score_spread":0.3103710834514109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998819602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029582824,0.995959,0.00030625073,0.0005921106,0.00035031897,0.000008626208,0.000015080472,0.000010075791,0.0024626297],"genre_scores_gemma":[0.0013831586,0.99608755,0.0003905767,0.0002833073,0.00021338873,0.000010778528,0.000026599857,0.0000015462979,0.0016030528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998553,0.000026144964,0.000013679783,0.000022128566,0.0000668925,0.000015815058],"domain_scores_gemma":[0.99991024,0.000026385795,0.000015337406,0.0000037303787,0.000031199368,0.000013004591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003884964,0.0006314396,0.0009778921,0.0012631026,0.00026902376,0.0006949231,0.00073524594,0.0012846207,0.0038426386],"category_scores_gemma":[0.00025885526,0.00020084438,0.00031704083,0.001164454,0.0004035981,0.0010280762,0.00049299956,0.0012997431,0.0041824384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098613775,0.000109453424,0.00011039407,0.010270286,0.000061699095,0.0004280896,0.000071524846,0.00057780027,0.011860221,0.0068389117,0.03774784,0.9318251],"study_design_scores_gemma":[0.00003037351,0.00013005675,0.0007744133,0.0015300714,0.00005160813,0.0015546506,0.000051477677,0.00015723814,0.0020473152,0.0028323324,0.9908229,0.000017651697],"about_ca_topic_score_codex":0.0007765982,"about_ca_topic_score_gemma":0.0014207595,"teacher_disagreement_score":0.0038426386,"about_ca_system_score_codex":0.0007305476,"about_ca_system_score_gemma":0.0007842417,"threshold_uncertainty_score":0.012854934},"labels":[],"label_agreement":null},{"id":"W2001083202","doi":"10.1517/14728222.2014.948419","title":"Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington’s disease","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Canadian Institutes of Health Research","keywords":"Metabotropic glutamate receptor 5; Huntington's disease; Metabotropic glutamate receptor 3; Metabotropic glutamate receptor 8; Metabotropic glutamate receptor 1; Metabotropic glutamate receptor; Glutamate receptor; Huntingtin; Metabotropic glutamate receptor 4; Metabotropic glutamate receptor 7; Neuroscience; Metabotropic glutamate receptor 6; Metabotropic receptor; Disease; Biology; Neurodegeneration; Metabotropic glutamate receptor 2; Receptor; Medicine; Genetics; Internal medicine","score_opus":0.05383114164183679,"score_gpt":0.35064254598909206,"score_spread":0.2968114043472553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001083202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001854562,0.99694973,0.00015408473,0.00057390047,0.00028092015,0.000008782828,0.000026953176,0.000009613576,0.0018105822],"genre_scores_gemma":[0.001188357,0.9966798,0.00025811204,0.00041119917,0.00021760951,0.000011471859,0.0000480463,0.0000017998856,0.0011836088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991536,0.000017519635,0.0000096377335,0.0000142821955,0.000032601543,0.000010534818],"domain_scores_gemma":[0.99991834,0.000027440352,0.000014890859,0.0000018180839,0.00002746732,0.000010100693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003164333,0.0005822645,0.0008823419,0.0011263357,0.0001824146,0.0006229289,0.00064795784,0.0010981251,0.0053606005],"category_scores_gemma":[0.00025080796,0.00013547143,0.00034989897,0.00093914004,0.00022494809,0.00073838,0.00045060282,0.0013102132,0.002917607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000936818,0.00007281967,0.00009756094,0.016885836,0.00008665994,0.00042260648,0.000062215084,0.00040509523,0.0042822035,0.0044739726,0.047085177,0.92603207],"study_design_scores_gemma":[0.00003762663,0.00013726584,0.0004946354,0.0037232414,0.00010759867,0.0014863679,0.000050931554,0.00015067426,0.0006090134,0.0021705828,0.99101603,0.000016078835],"about_ca_topic_score_codex":0.0007163153,"about_ca_topic_score_gemma":0.002035653,"teacher_disagreement_score":0.0053606005,"about_ca_system_score_codex":0.00046469382,"about_ca_system_score_gemma":0.0005777745,"threshold_uncertainty_score":0.017933011},"labels":[],"label_agreement":null},{"id":"W2003118255","doi":"10.1517/14728222.2012.668185","title":"14-3-3 zeta as novel molecular target for cancer therapy","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; IONICS Mass Spectrometry (Canada); York University","funders":"","keywords":"Cancer; Cancer therapy; Cancer cell; Targeted therapy; Cancer research; Signal transduction; Medicine; Bioinformatics; Biology; Internal medicine; Cell biology","score_opus":0.10000229334897405,"score_gpt":0.41688283239587076,"score_spread":0.3168805390468967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003118255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001929677,0.99470633,0.00038197005,0.0016592206,0.0010168107,0.0000135857745,0.000044335568,0.000019219897,0.0019655114],"genre_scores_gemma":[0.0012241735,0.995447,0.00033059824,0.0008721225,0.00047377992,0.00001705492,0.00006850675,0.000002972793,0.0015637787],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99983037,0.000034557885,0.00001602822,0.00003081484,0.000068484806,0.00001975994],"domain_scores_gemma":[0.999798,0.000070591464,0.000027398795,0.0000059744825,0.00007652005,0.0000215292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046902683,0.0006115801,0.00081704673,0.0011952707,0.00020090817,0.00079598965,0.000778281,0.001351541,0.0044491272],"category_scores_gemma":[0.000499843,0.00018004054,0.00049009087,0.0010637302,0.00037290153,0.0010387488,0.00044924178,0.0021004884,0.0026094117],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010072528,0.00006895765,0.00013045913,0.012714444,0.000081065045,0.0002418397,0.00004118462,0.00060520414,0.0040620347,0.006970592,0.08517484,0.8898086],"study_design_scores_gemma":[0.000019873112,0.000076018274,0.00022193001,0.00151758,0.000056399826,0.00059995387,0.000027432168,0.00011366186,0.0007350259,0.0019737396,0.99464756,0.00001080161],"about_ca_topic_score_codex":0.00079360994,"about_ca_topic_score_gemma":0.0017982218,"teacher_disagreement_score":0.0044491272,"about_ca_system_score_codex":0.0009351118,"about_ca_system_score_gemma":0.0010636157,"threshold_uncertainty_score":0.014883816},"labels":[],"label_agreement":null},{"id":"W2021574933","doi":"10.1517/14728222.12.4.425","title":"Potential therapeutic targets for Parkinson's disease","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Nuclear Receptors and Signaling","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; BC Innovation Council","funders":"","keywords":"Dopamine; Parkinson's disease; Disease; Medicine; Substantia nigra; Dopaminergic; Neuroscience; Neuroprotection; Levodopa; Bioinformatics; Psychology; Pharmacology; Biology; Internal medicine","score_opus":0.08828067706765923,"score_gpt":0.3537629155227678,"score_spread":0.26548223845510854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021574933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030589146,0.97086304,0.0022032727,0.00919632,0.0013698223,0.000076824566,0.00020128701,0.000085374435,0.0129451845],"genre_scores_gemma":[0.03190931,0.94768775,0.0050774342,0.0041861394,0.001074699,0.0001689194,0.00041301927,0.000024070772,0.009458687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980134,0.000058726302,0.000016003516,0.00003105897,0.000059688442,0.000033203312],"domain_scores_gemma":[0.9997818,0.00006594516,0.00004565005,0.000007059284,0.00006474743,0.00003480529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057215325,0.0005669827,0.000748952,0.0008431688,0.0003559532,0.001133521,0.0005748478,0.0014181222,0.011465235],"category_scores_gemma":[0.00044240424,0.00012399943,0.0005742947,0.0005153632,0.00040698957,0.0008105163,0.00058227894,0.0018689246,0.0026245173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048226755,0.0004354395,0.0008460339,0.015065732,0.00019724556,0.0018148719,0.00029479864,0.00089133106,0.040492695,0.031188492,0.08173204,0.82655907],"study_design_scores_gemma":[0.00022541804,0.0009567981,0.0017164019,0.0038174214,0.00025934572,0.0030592205,0.00021857707,0.0005676095,0.006406255,0.015225524,0.96750957,0.000037861624],"about_ca_topic_score_codex":0.0003142048,"about_ca_topic_score_gemma":0.0013188601,"teacher_disagreement_score":0.011465235,"about_ca_system_score_codex":0.0006624843,"about_ca_system_score_gemma":0.0007295096,"threshold_uncertainty_score":0.038354993},"labels":[],"label_agreement":null},{"id":"W2024420229","doi":"10.1517/14728222.11.3.307","title":"Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"","keywords":"TRPV1; Transient receptor potential channel; Hyperalgesia; Capsaicin; Pharmacology; Inflammation; Neuropathic pain; Nociception; Mediator; Chemistry; Receptor; Medicine; Internal medicine","score_opus":0.03983669129351819,"score_gpt":0.325767139963117,"score_spread":0.2859304486695988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024420229","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031858054,0.99573815,0.0005002477,0.00071225327,0.00042892984,0.000020307038,0.000021886606,0.000020692438,0.0022389048],"genre_scores_gemma":[0.001324426,0.99474406,0.0009076048,0.00050296757,0.00034256547,0.000026082205,0.0000534586,0.0000033002912,0.0020955615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998078,0.000039915547,0.000015782727,0.000024837243,0.000086228254,0.00002558293],"domain_scores_gemma":[0.99985874,0.00004131164,0.000022339753,0.0000049290243,0.000047573398,0.000025147458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006369657,0.0011684607,0.0015171668,0.0017526028,0.0002763665,0.00071124965,0.0009879887,0.0014417769,0.0071602524],"category_scores_gemma":[0.00039578168,0.00022265846,0.0004381884,0.0016572982,0.00042343343,0.0013751162,0.0004524131,0.0015789497,0.005172106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017440024,0.00024000692,0.000117636555,0.011423761,0.000090657646,0.00040799504,0.00006777096,0.0005681005,0.0095971925,0.0030423296,0.041609183,0.93266094],"study_design_scores_gemma":[0.0001334853,0.00031091244,0.0009292081,0.0021526625,0.00013771102,0.0019023895,0.000082447965,0.00020036184,0.0018412318,0.002845547,0.98943806,0.000026110998],"about_ca_topic_score_codex":0.00072876085,"about_ca_topic_score_gemma":0.0015158729,"teacher_disagreement_score":0.0071602524,"about_ca_system_score_codex":0.0005459194,"about_ca_system_score_gemma":0.000774926,"threshold_uncertainty_score":0.023953438},"labels":[],"label_agreement":null},{"id":"W2029679395","doi":"10.1517/14728222.2013.729042","title":"Targeting class I histone deacetylases in cancer therapy","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"HDAC8; Histone deacetylase; Histone; Histone deacetylase 5; Epigenetics; Biology; HDAC1; Cancer research; HDAC11; Cancer; Cancer cell; Gene; Genetics","score_opus":0.10723395404369976,"score_gpt":0.4323709437233718,"score_spread":0.3251369896796721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029679395","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013620358,0.9958865,0.0003231611,0.0008583628,0.0006313084,0.00001108728,0.000027847273,0.000022631297,0.0021028628],"genre_scores_gemma":[0.000942779,0.9961128,0.00037239958,0.0005131019,0.00033771872,0.000012335137,0.000046765064,0.0000031837594,0.0016588093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998385,0.000027755928,0.000012158994,0.000028829521,0.00007242124,0.000020321762],"domain_scores_gemma":[0.99985135,0.000044207412,0.000024492267,0.0000054643483,0.000054714168,0.000019784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044648044,0.0007956541,0.0010172074,0.0011223995,0.00022382937,0.0006173736,0.00084440253,0.0011340642,0.0052697654],"category_scores_gemma":[0.00041188815,0.00019028645,0.00044846477,0.0011832588,0.00043354943,0.0009167071,0.0005527863,0.0025144734,0.004511525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087572815,0.00007471087,0.00008527092,0.00769836,0.00006638386,0.00016823274,0.00003253788,0.00045503266,0.0034811047,0.0043242206,0.07501856,0.9085081],"study_design_scores_gemma":[0.000025887699,0.000076309894,0.00028138442,0.0013405543,0.000045772424,0.0007336282,0.000018227876,0.00010539305,0.000632342,0.0015220677,0.99520713,0.000011247834],"about_ca_topic_score_codex":0.0010366426,"about_ca_topic_score_gemma":0.0022262586,"teacher_disagreement_score":0.0052697654,"about_ca_system_score_codex":0.00084952894,"about_ca_system_score_gemma":0.00070546777,"threshold_uncertainty_score":0.017629147},"labels":[],"label_agreement":null},{"id":"W2030491415","doi":"10.1517/14728222.2011.558008","title":"Targeting the anaphase promoting complex: common pathways for viral infection and cancer therapy","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Anaphase-promoting complex; CDC20; Cancer cell; Cell biology; Biology; Mitosis; Ubiquitin ligase; Cell cycle; Cancer research; Cancer; Cell cycle checkpoint; Ubiquitin; Anaphase; Genetics","score_opus":0.08959492628850026,"score_gpt":0.3658332928830469,"score_spread":0.27623836659454665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030491415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001434053,0.9960471,0.0005909918,0.00069524505,0.00051731424,0.000014140144,0.000026211463,0.000022072809,0.0019435675],"genre_scores_gemma":[0.0009523804,0.9950028,0.00059223536,0.00061507546,0.00044686365,0.000024384239,0.000070031616,0.0000051823354,0.00229099],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997731,0.000041143598,0.000024493855,0.000044418717,0.00009379967,0.000022990214],"domain_scores_gemma":[0.99982136,0.000049114435,0.00003760538,0.000008974685,0.00005464896,0.000028245717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005125873,0.0010562787,0.0013787524,0.0019799306,0.00030261747,0.0009996054,0.0008434705,0.0016004224,0.004760786],"category_scores_gemma":[0.00041927322,0.0002731747,0.00050615805,0.0015803274,0.00061861257,0.0015151269,0.0007919646,0.0024357534,0.0042054374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009561854,0.00008849757,0.000093473755,0.009101651,0.000076985976,0.00038431384,0.00004740056,0.00042544794,0.006665857,0.0076370407,0.07068441,0.9046993],"study_design_scores_gemma":[0.000021741187,0.000069086964,0.00030152846,0.0012104153,0.000035915615,0.0016994581,0.000021772998,0.00009867836,0.00096578174,0.0019846614,0.9935762,0.000014645271],"about_ca_topic_score_codex":0.0007420767,"about_ca_topic_score_gemma":0.0018513968,"teacher_disagreement_score":0.004760786,"about_ca_system_score_codex":0.0011256438,"about_ca_system_score_gemma":0.0007287872,"threshold_uncertainty_score":0.015926361},"labels":[],"label_agreement":null},{"id":"W2030592653","doi":"10.1517/14728222.2013.812074","title":"CCN2: a novel, specific and valid target for anti-fibrotic drug intervention","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Matricellular protein; CTGF; Fibrosis; Growth factor; Connective tissue; Cancer research; Biology; Medicine; Cell biology; Immunology; Extracellular matrix; Pathology; Internal medicine; Receptor","score_opus":0.10634056850119665,"score_gpt":0.4031384518948709,"score_spread":0.29679788339367424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030592653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021345627,0.99426526,0.0005660542,0.0016730361,0.00090064417,0.000014340694,0.00005536035,0.000018654804,0.0022931867],"genre_scores_gemma":[0.0018894706,0.9939891,0.00055703457,0.00093630754,0.0006104971,0.000021687236,0.000099970144,0.000003836862,0.0018920635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998252,0.000029447858,0.00001447018,0.00003628808,0.00007359532,0.000021162772],"domain_scores_gemma":[0.9997969,0.00006442878,0.000030407082,0.0000067115266,0.000075011325,0.00002659693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005434054,0.0006766746,0.0010236402,0.0009562502,0.00024471694,0.0007541767,0.00064780004,0.0013411095,0.004734789],"category_scores_gemma":[0.0004760367,0.00018663515,0.00039763364,0.00079057686,0.0004906728,0.001113725,0.00049922254,0.0021339545,0.00327946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097333046,0.00005645946,0.00011828561,0.012501269,0.000073823,0.0003293132,0.00004152837,0.00028558652,0.009373394,0.009077103,0.08144457,0.8866013],"study_design_scores_gemma":[0.000025355572,0.00007483319,0.00032093909,0.0015435921,0.000044660737,0.0010755352,0.000024362665,0.00012391737,0.0012917671,0.0019594517,0.9934999,0.000015758127],"about_ca_topic_score_codex":0.0005708895,"about_ca_topic_score_gemma":0.001313226,"teacher_disagreement_score":0.004734789,"about_ca_system_score_codex":0.0006708436,"about_ca_system_score_gemma":0.0008504194,"threshold_uncertainty_score":0.015839458},"labels":[],"label_agreement":null},{"id":"W2036055666","doi":"10.1517/14728220802631876","title":"Defining protein interactions that regulate disease progression","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Protein–protein interaction; Computational biology; Biology; Disease; Function (biology); Protein function; Cell biology; Bioinformatics; Genetics; Medicine; Gene","score_opus":0.03703699343782864,"score_gpt":0.31551305239185434,"score_spread":0.2784760589540257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036055666","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49668464,0.43314084,0.030342305,0.007700075,0.00062964356,0.00015127806,0.0015185522,0.00048018625,0.029352492],"genre_scores_gemma":[0.9087283,0.07732067,0.0071513727,0.0015011341,0.0003869455,0.00008910557,0.00078942976,0.00005810648,0.003974929],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995888,0.00009334631,0.000040688188,0.00012264164,0.00010226688,0.000052412943],"domain_scores_gemma":[0.9996164,0.00007925206,0.00018912986,0.000018112858,0.000057818266,0.000039372797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074088183,0.00038378465,0.0005203863,0.0010322891,0.00042236975,0.0014814255,0.00032716015,0.0008074255,0.0015635474],"category_scores_gemma":[0.0007805977,0.00016411251,0.00024077484,0.0008736848,0.00060877355,0.0009799546,0.0005003087,0.0008459223,0.00055249996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014325727,0.00023820641,0.08269774,0.0016884704,0.00042294487,0.001733816,0.0007953901,0.0030198775,0.56866235,0.047006603,0.012599558,0.27970245],"study_design_scores_gemma":[0.00013955841,0.00096574717,0.392839,0.00058332353,0.0006142896,0.007979229,0.0013891369,0.010755266,0.18202741,0.054349843,0.34820047,0.00015669067],"about_ca_topic_score_codex":0.0006972047,"about_ca_topic_score_gemma":0.00080106995,"teacher_disagreement_score":0.0015635474,"about_ca_system_score_codex":0.0007025087,"about_ca_system_score_gemma":0.00029255726,"threshold_uncertainty_score":0.0052306056},"labels":[],"label_agreement":null},{"id":"W2038196376","doi":"10.1517/14728222.5.4.443","title":"Targeting HIV-1 integrase","year":2001,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Hyacinthe; Université de Montréal","funders":"","keywords":"Integrase; Integrase inhibitor; Reverse transcriptase; Virology; Biology; Human immunodeficiency virus (HIV); Virus; Protease; Computational biology; Enzyme; Genetics; Antiretroviral therapy; RNA; Viral load; Gene; Biochemistry","score_opus":0.031080944117598503,"score_gpt":0.3157572426580873,"score_spread":0.2846762985404888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038196376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13974667,0.7666327,0.019146645,0.006663697,0.001352703,0.00031644167,0.00045136866,0.0002789599,0.06541079],"genre_scores_gemma":[0.42322537,0.5242981,0.0119011225,0.002822932,0.00064126163,0.0002079552,0.0007263308,0.000029695611,0.036147244],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999206,0.000014798477,0.0000031533027,0.000014638488,0.00002701829,0.000019830954],"domain_scores_gemma":[0.9999739,0.000006807249,0.0000047900235,0.0000016885397,0.000006867441,0.0000059698596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015570819,0.0004128298,0.00037524433,0.00031035533,0.00018062825,0.0005116545,0.00035590434,0.00056940864,0.0024100866],"category_scores_gemma":[0.00011674967,0.000092410206,0.00017267658,0.00017378044,0.00016605652,0.0002601242,0.00020936842,0.0006465951,0.001097767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004923398,0.0002923881,0.00051889813,0.0020623785,0.000052339274,0.0009503851,0.00011051425,0.0007613155,0.5425794,0.007698781,0.012207884,0.4322733],"study_design_scores_gemma":[0.00032630024,0.0022254672,0.0031167814,0.00034752657,0.0001766582,0.006857024,0.00010289858,0.0025089153,0.35235474,0.0038021295,0.62814987,0.000031693493],"about_ca_topic_score_codex":0.000359726,"about_ca_topic_score_gemma":0.00075930834,"teacher_disagreement_score":0.0024100866,"about_ca_system_score_codex":0.0003827751,"about_ca_system_score_gemma":0.0002243248,"threshold_uncertainty_score":0.0080625415},"labels":[],"label_agreement":null},{"id":"W2040110061","doi":"10.1517/14728220802607363","title":"Melanoma: targeting signaling pathways and RaLP","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Waterloo","keywords":"Melanoma; Metastatic melanoma; Medicine; Cancer research; Signal transduction; Disease; Cancer; Biology; Internal medicine; Genetics","score_opus":0.03357481669340083,"score_gpt":0.26063119984644734,"score_spread":0.2270563831530465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040110061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16361687,0.7570295,0.019061245,0.014490854,0.0007790087,0.00021353716,0.0005387793,0.00059786,0.043672435],"genre_scores_gemma":[0.48044166,0.48859197,0.0107729025,0.0023496985,0.0005576128,0.00012346324,0.00048287012,0.000057281195,0.016622595],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99993646,0.000016309037,0.000003254425,0.000010937641,0.000017855964,0.000015245672],"domain_scores_gemma":[0.999977,0.0000051466664,0.0000069148186,0.0000014917496,0.0000042504457,0.0000051675293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018873482,0.00049978105,0.0002901614,0.00034102463,0.00016505914,0.00040782848,0.00021855129,0.00042895792,0.0016645335],"category_scores_gemma":[0.0000821302,0.00011750053,0.00019950604,0.00020937381,0.00028443412,0.0003147739,0.00026176596,0.0006574434,0.0008516691],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060874486,0.00018491244,0.0007562656,0.0028120656,0.000055370292,0.0026108387,0.00010922296,0.0011022337,0.78641856,0.010280657,0.008656714,0.18640442],"study_design_scores_gemma":[0.0002560825,0.0013670224,0.0073960884,0.00039404258,0.00020001107,0.016686136,0.00018504563,0.0029436012,0.5241778,0.009616637,0.43672952,0.00004804939],"about_ca_topic_score_codex":0.0005107601,"about_ca_topic_score_gemma":0.00080676837,"teacher_disagreement_score":0.0016645335,"about_ca_system_score_codex":0.0004724176,"about_ca_system_score_gemma":0.00031642907,"threshold_uncertainty_score":0.005568385},"labels":[],"label_agreement":null},{"id":"W2043449485","doi":"10.1517/14728222.2014.855199","title":"Targeting the type III secretion system to treat bacterial infections","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Escherichia coli research studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Secretion; Type three secretion system; Virulence; Biology; Antibiotics; Mode of action; Computational biology; Microbiology; Biochemistry","score_opus":0.04880362219025401,"score_gpt":0.3625933157686126,"score_spread":0.31378969357835856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043449485","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020039482,0.99493045,0.00039875697,0.00074026507,0.0008743388,0.00001925419,0.000042263127,0.000027002987,0.0027673598],"genre_scores_gemma":[0.00082752045,0.99640465,0.0003596529,0.000524031,0.00023882746,0.000018160139,0.0000545525,0.0000032518496,0.0015693868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982363,0.000023833561,0.000014359384,0.000026868289,0.00009137923,0.000020031988],"domain_scores_gemma":[0.9998758,0.000031043604,0.000021404576,0.0000042607867,0.00004986942,0.000017628665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039510784,0.00087747455,0.0010854179,0.0014583464,0.0001947032,0.0006526865,0.0008262749,0.0011549602,0.004572306],"category_scores_gemma":[0.00040395473,0.00021855171,0.00049495173,0.001094812,0.00033976094,0.0008806801,0.0005323338,0.002016907,0.0049513066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008123126,0.00008887091,0.000068461726,0.01331499,0.0000827928,0.00019900683,0.00004194479,0.0004382025,0.0066974806,0.0039103557,0.09119952,0.8838771],"study_design_scores_gemma":[0.000026951275,0.000090936446,0.0002409244,0.0017129828,0.000038867987,0.000559273,0.000019743056,0.00008623544,0.0006820663,0.00093543925,0.9955959,0.000010752536],"about_ca_topic_score_codex":0.0007870875,"about_ca_topic_score_gemma":0.0013986742,"teacher_disagreement_score":0.004572306,"about_ca_system_score_codex":0.0006622631,"about_ca_system_score_gemma":0.0006270356,"threshold_uncertainty_score":0.015295863},"labels":[],"label_agreement":null},{"id":"W2044145734","doi":"10.1517/14728220903241625","title":"Translation initiation: a critical signalling node in cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"PI3K/AKT/mTOR pathway; EIF4E; Translation (biology); Biology; Carcinogenesis; Regulator; P70-S6 Kinase 1; Cell biology; Cancer; Signal transduction; Messenger RNA; Genetics; Gene","score_opus":0.1222404739022367,"score_gpt":0.43054058048364224,"score_spread":0.30830010658140555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044145734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009244141,0.9981128,0.00012484548,0.0005102442,0.00030848943,0.0000034744648,0.000010101664,0.000008582481,0.0008291418],"genre_scores_gemma":[0.0006026235,0.9980489,0.0001637934,0.0002973738,0.00022740723,0.0000051392763,0.000019109428,0.000001524854,0.0006341927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998073,0.000034262666,0.000025310925,0.00003677594,0.00007437216,0.000021997392],"domain_scores_gemma":[0.9998702,0.000042891563,0.000023502995,0.000004748503,0.000039291557,0.000019382143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048842805,0.00092381804,0.0017150743,0.0010826658,0.00035612463,0.0011038113,0.0011253088,0.0017767528,0.0033720357],"category_scores_gemma":[0.00033502965,0.00031109268,0.00030997684,0.0016475517,0.00078408176,0.0016915986,0.00074486644,0.0022008533,0.0049633686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001770276,0.000053897817,0.00010023649,0.014414626,0.00006547299,0.00045076472,0.000080547434,0.00042356958,0.005868354,0.009743211,0.05285897,0.9157633],"study_design_scores_gemma":[0.000022820572,0.00006673981,0.00031748062,0.0011288839,0.000033200064,0.0010641655,0.00005031793,0.00006804166,0.0006807817,0.0034698735,0.9930842,0.000013480545],"about_ca_topic_score_codex":0.00083514367,"about_ca_topic_score_gemma":0.0014527397,"teacher_disagreement_score":0.0033720357,"about_ca_system_score_codex":0.001222582,"about_ca_system_score_gemma":0.0011958753,"threshold_uncertainty_score":0.011280596},"labels":[],"label_agreement":null},{"id":"W2060603638","doi":"10.1517/14728222.10.2.239","title":"Natriuretic peptides as therapeutic targets","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Natriuretic peptide; Brain natriuretic peptide; NPR1; Neprilysin; NPR2; Internal medicine; Atrial natriuretic peptide; Heart failure; Medicine; Pharmacology; Endocrinology; Chemistry; Biochemistry; Enzyme","score_opus":0.06405361970051882,"score_gpt":0.3794149255980568,"score_spread":0.31536130589753797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060603638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001511774,0.9960508,0.00017198414,0.0008072901,0.00042532803,0.000007728108,0.000013461477,0.000010607651,0.0023616864],"genre_scores_gemma":[0.0012448453,0.99442154,0.00047967557,0.0008478104,0.00057093706,0.000022844812,0.000045469304,0.0000031423403,0.002363747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972683,0.0000668635,0.000023445118,0.000037997055,0.00011136145,0.000033467746],"domain_scores_gemma":[0.9997663,0.00010122062,0.000029096018,0.000009430198,0.00006147268,0.000032487937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009257531,0.0010981708,0.001730325,0.0015308696,0.0002549335,0.00095895125,0.0009267579,0.0015817011,0.0067983405],"category_scores_gemma":[0.00061411655,0.00023609056,0.00038274424,0.0011619848,0.000466574,0.0016608293,0.0005210911,0.002209114,0.0052433116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001590182,0.00016871988,0.000106807216,0.0063849892,0.000061663544,0.0004656058,0.00006654758,0.00044164894,0.0034478384,0.0050525344,0.05400074,0.92964387],"study_design_scores_gemma":[0.000095653224,0.00016145108,0.0005317731,0.0018884807,0.000057656434,0.0013437868,0.000058746864,0.00013667994,0.00064778683,0.0029998326,0.99206245,0.000015686468],"about_ca_topic_score_codex":0.0004911499,"about_ca_topic_score_gemma":0.0011813274,"teacher_disagreement_score":0.0067983405,"about_ca_system_score_codex":0.00065174326,"about_ca_system_score_gemma":0.00070870394,"threshold_uncertainty_score":0.022742689},"labels":[],"label_agreement":null},{"id":"W2060807298","doi":"10.1517/14728222.2014.915314","title":"Thymic stromal lymphopoietin: a central regulator of allergic asthma","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Thymic stromal lymphopoietin; Regulator; Asthma; Immunology; Allergic asthma; Medicine; Negative regulator; Master regulator; Biology; Cell biology; Signal transduction; Genetics","score_opus":0.03727572520912862,"score_gpt":0.34708286123446097,"score_spread":0.30980713602533233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060807298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000094094874,0.998201,0.0000761447,0.0004723874,0.00030802042,0.000004535498,0.000023813926,0.0000064686956,0.0008135404],"genre_scores_gemma":[0.001040653,0.99738735,0.000104347,0.0003355864,0.00036305544,0.000006825713,0.00004663456,0.0000014739652,0.0007141242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983764,0.00002973092,0.000019014238,0.000027835695,0.000065642824,0.000019980087],"domain_scores_gemma":[0.9998299,0.00005054583,0.000037702943,0.0000039992347,0.000054210905,0.000023585755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042894835,0.0006465581,0.0010615177,0.00088990445,0.00020298251,0.00091354985,0.0006755833,0.0010330155,0.0055579077],"category_scores_gemma":[0.00041825208,0.00016002572,0.0003374699,0.0010577333,0.0003212595,0.00080860127,0.00054634287,0.0014988112,0.0032333403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011787885,0.000037966594,0.0002045982,0.018713415,0.00012837467,0.0001789925,0.000042084666,0.00024875638,0.0030369714,0.0036793295,0.04870047,0.9249111],"study_design_scores_gemma":[0.000034929595,0.00006531666,0.00089916773,0.0032041206,0.000107622334,0.00081372523,0.000045351095,0.000070762355,0.0004248275,0.0017895178,0.9925327,0.000012033667],"about_ca_topic_score_codex":0.00060043106,"about_ca_topic_score_gemma":0.0009618216,"teacher_disagreement_score":0.0055579077,"about_ca_system_score_codex":0.00047399907,"about_ca_system_score_gemma":0.0010344116,"threshold_uncertainty_score":0.018593013},"labels":[],"label_agreement":null},{"id":"W2062432510","doi":"10.1517/14728222.9.1.195","title":"B cells and autoimmunity 2004: new concepts and therapeutic perspectives","year":2005,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"University of Washington","keywords":"Autoimmunity; Immunology; Autoimmune disease; Disease; Biology; Neuroscience; Medicine; Immune system; Antibody; Pathology","score_opus":0.022210269878138063,"score_gpt":0.28691004085313465,"score_spread":0.2646997709749966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062432510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053848216,0.9625129,0.0016638605,0.02771732,0.003986692,0.000008403054,0.000015949297,0.000034417346,0.0035219898],"genre_scores_gemma":[0.009825502,0.9493551,0.003606152,0.015534602,0.016760986,0.000028539622,0.000038845763,0.000012600626,0.0048376764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949634,0.00019374814,0.000037909034,0.000055134286,0.00015525326,0.00006164333],"domain_scores_gemma":[0.9993981,0.0002429219,0.000046098634,0.00004153962,0.00013062792,0.0001407973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024022197,0.00077218824,0.0013508757,0.0011848058,0.0005493797,0.0022543364,0.0010084262,0.004076986,0.008491391],"category_scores_gemma":[0.00082739687,0.00024822418,0.00057680934,0.00074347755,0.001947264,0.0037117167,0.0010315621,0.0044701174,0.0026902694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049272564,0.0003270889,0.0003637239,0.0036185803,0.00009257174,0.0011009356,0.00030206214,0.0004980891,0.010085676,0.079901464,0.15311757,0.75009954],"study_design_scores_gemma":[0.0000922281,0.00025530797,0.0003990302,0.0007934494,0.000057133995,0.001715563,0.0002337486,0.00027622437,0.00092381414,0.04421383,0.9510169,0.000022694647],"about_ca_topic_score_codex":0.00040922948,"about_ca_topic_score_gemma":0.00092247414,"teacher_disagreement_score":0.008491391,"about_ca_system_score_codex":0.0010050165,"about_ca_system_score_gemma":0.00096502376,"threshold_uncertainty_score":0.02840656},"labels":[],"label_agreement":null},{"id":"W2066931715","doi":"10.1517/14728222.2014.937426","title":"Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"EIF4E; Translation (biology); Cancer research; Cancer; Biology; Eukaryotic initiation factor; Phosphorylation; EIF4A1; Function (biology); Signal transduction; Eukaryotic translation; Computational biology; Medicine; Cell biology; Messenger RNA; Gene; Genetics","score_opus":0.07200116459995802,"score_gpt":0.356964962984781,"score_spread":0.28496379838482294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066931715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010921312,0.9972166,0.00018415721,0.0008339273,0.0005050662,0.000005366745,0.000020117648,0.000010878925,0.0011146301],"genre_scores_gemma":[0.00083198084,0.99689156,0.0002576904,0.00064073846,0.00038686127,0.000008912752,0.000040870455,0.0000023554405,0.0009391267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998653,0.000026607857,0.000014883638,0.000023220493,0.00005318545,0.000016829765],"domain_scores_gemma":[0.9998574,0.000055063912,0.000021232168,0.000004302586,0.000043988788,0.000018041534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043303627,0.0006273148,0.0010425369,0.0012353961,0.0002232028,0.000679589,0.0006975337,0.0012237815,0.0040150406],"category_scores_gemma":[0.00046595,0.00017913007,0.00047421013,0.0012746376,0.00034156523,0.0010712199,0.0005529504,0.0021411905,0.0026539012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007925066,0.000050680435,0.00009882375,0.010863503,0.00006783557,0.0002971153,0.000036706817,0.00034563904,0.0025378563,0.0037815734,0.06525896,0.9165821],"study_design_scores_gemma":[0.000020282445,0.00006505329,0.00031754657,0.0018073496,0.00005310437,0.0012584052,0.000025123656,0.00009624583,0.00039456744,0.0016398297,0.9943104,0.000012064616],"about_ca_topic_score_codex":0.000532845,"about_ca_topic_score_gemma":0.001244237,"teacher_disagreement_score":0.0040150406,"about_ca_system_score_codex":0.00066921144,"about_ca_system_score_gemma":0.00070573675,"threshold_uncertainty_score":0.013431609},"labels":[],"label_agreement":null},{"id":"W2068057735","doi":"10.1517/14728222.10.4.515","title":"Targeting the dopamine D<sub>2</sub>receptor in schizophrenia","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":302,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs","funders":"","keywords":"Dopamine receptor D2; Antipsychotic; Dopamine; Haloperidol; Psychosis; Schizophrenia (object-oriented programming); Parkinsonism; Pharmacology; Dopamine receptor; Typical antipsychotic; Dopamine hypothesis of schizophrenia; Medicine; Dopamine receptor D3; Neuroscience; Psychology; Internal medicine; Psychiatry; Atypical antipsychotic; Disease","score_opus":0.06421932111572513,"score_gpt":0.34081017605572345,"score_spread":0.2765908549399983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068057735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027957265,0.9967655,0.0002336746,0.00038481737,0.00022159277,0.000008475437,0.000019086183,0.000013724416,0.0020735664],"genre_scores_gemma":[0.0012138137,0.99653167,0.0003440385,0.00024397601,0.00017248596,0.000010081825,0.000030959138,0.0000019009769,0.0014511185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989223,0.000018843291,0.000011951395,0.000018208968,0.000044741868,0.00001408874],"domain_scores_gemma":[0.99989295,0.00003070632,0.000017883938,0.0000034633804,0.0000369949,0.000018091521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052078924,0.0008798791,0.0014112152,0.001491579,0.00021029974,0.00063335354,0.00083139626,0.0010664475,0.0036161628],"category_scores_gemma":[0.0002833693,0.00022189699,0.00031527336,0.001275512,0.00039166427,0.00088059035,0.0004268617,0.0010028004,0.003925621],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012618188,0.00009566539,0.00015731817,0.008400566,0.000051173964,0.00047556058,0.000043825712,0.00044137822,0.0045095496,0.0022475077,0.03492441,0.94852704],"study_design_scores_gemma":[0.0000772554,0.0001801976,0.0013153738,0.0016820751,0.00007851475,0.0024468794,0.00007102456,0.0001933072,0.0009830372,0.0020027373,0.9909486,0.00002100217],"about_ca_topic_score_codex":0.0014252017,"about_ca_topic_score_gemma":0.003942202,"teacher_disagreement_score":0.0036161628,"about_ca_system_score_codex":0.00061965495,"about_ca_system_score_gemma":0.00064023794,"threshold_uncertainty_score":0.0120972395},"labels":[],"label_agreement":null},{"id":"W2071096373","doi":"10.1517/14728222.8.6.527","title":"Therapeutic targets for antimetastatic therapy","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Metastasis; Medicine; Cancer; Cancer metastasis; Cancer cell; Cancer therapy; Oncology; Cancer research; Internal medicine","score_opus":0.1280737700992592,"score_gpt":0.41636560468693457,"score_spread":0.2882918345876754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071096373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035586717,0.98851216,0.0011024105,0.0017500776,0.0009632893,0.000032099597,0.000042477513,0.00002853465,0.0072132354],"genre_scores_gemma":[0.0022761233,0.9882901,0.0017238358,0.0015246784,0.00056937983,0.00005138478,0.00010702412,0.0000060828706,0.0054514827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965906,0.00007365456,0.000023886063,0.00004639686,0.00016054622,0.00003649213],"domain_scores_gemma":[0.999845,0.000054289434,0.000019623292,0.000009227491,0.000052111394,0.000019634916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066379254,0.0010449183,0.0015042601,0.0017392973,0.00035739254,0.0010562555,0.0009997602,0.0020422146,0.010355209],"category_scores_gemma":[0.00045801696,0.00025400546,0.0006503716,0.001233943,0.0005605849,0.0013938965,0.00057219056,0.0026811718,0.0067431596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012223065,0.0002147845,0.00015814637,0.009590975,0.00007405424,0.0008359515,0.00009316072,0.0006575995,0.01715966,0.013723672,0.075087495,0.88228226],"study_design_scores_gemma":[0.000040511055,0.000096119795,0.00027209992,0.001315879,0.000041776177,0.0013252324,0.000032551732,0.00012743172,0.0014260865,0.0034202794,0.99189055,0.000011465704],"about_ca_topic_score_codex":0.00063663034,"about_ca_topic_score_gemma":0.001615486,"teacher_disagreement_score":0.010355209,"about_ca_system_score_codex":0.00096309633,"about_ca_system_score_gemma":0.0008842023,"threshold_uncertainty_score":0.034641623},"labels":[],"label_agreement":null},{"id":"W2085456770","doi":"10.1517/14728222.11.8.993","title":"Cathelicidins and functional analogues as antisepsis molecules","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Health Canada; Genome British Columbia; Foundation for the National Institutes of Health","keywords":"Cathelicidin; Antimicrobial; Innate immune system; Antimicrobial peptides; Biology; Pathogen; Limiting; Immune system; Sepsis; Antibiotics; Microbiology; Immunology","score_opus":0.08206612277757039,"score_gpt":0.349240141007834,"score_spread":0.26717401823026365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085456770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033839382,0.9973043,0.00025752315,0.00019996964,0.00035967532,0.0000077552395,0.000010686819,0.000008713457,0.0015130244],"genre_scores_gemma":[0.0016106149,0.9953245,0.0004915819,0.00025546312,0.00026330783,0.0000145689655,0.000031978463,0.0000018243617,0.0020061887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998202,0.000037794878,0.000017767636,0.00003137366,0.00007422057,0.000018732031],"domain_scores_gemma":[0.99987257,0.000045563986,0.000020797665,0.0000062472236,0.000035089484,0.000019837322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006122374,0.0009540797,0.001115468,0.0012227929,0.00021712294,0.00070512324,0.00084724,0.0011095041,0.0030897374],"category_scores_gemma":[0.0003981531,0.00027280927,0.0003136903,0.0015244358,0.00043395674,0.0014030194,0.0005115679,0.0014491251,0.0029450646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017416342,0.00012263315,0.000122062345,0.008554682,0.000046898433,0.00047763277,0.00006411198,0.00064422714,0.0144017795,0.007098898,0.02304188,0.94525105],"study_design_scores_gemma":[0.000040971405,0.00014338568,0.00035580524,0.000756138,0.000023662686,0.001104741,0.000032357773,0.00010914263,0.00207518,0.0016947093,0.99365187,0.0000119425],"about_ca_topic_score_codex":0.00039983774,"about_ca_topic_score_gemma":0.0006520517,"teacher_disagreement_score":0.0030897374,"about_ca_system_score_codex":0.0005580641,"about_ca_system_score_gemma":0.000476866,"threshold_uncertainty_score":0.010336161},"labels":[],"label_agreement":null},{"id":"W2098564211","doi":"10.1517/14728222.2012.680955","title":"Targeting pain mediators induced by injured nerve-derived COX2 and PGE2 to treat neuropathic pain","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"","keywords":"Medicine; Neuropathic pain; Nerve injury; Hyperalgesia; Allodynia; Neurotrophin; Neuroscience; Population; Dorsal root ganglion; Neurotrophic factors; Nerve growth factor; Chronic pain; Peripheral nerve injury; Sensory system; Nociception; Anesthesia; Bioinformatics; Internal medicine; Sciatic nerve; Psychology; Biology; Physical therapy; Receptor","score_opus":0.06349108897793913,"score_gpt":0.3476302048239426,"score_spread":0.28413911584600343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098564211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007639478,0.9956137,0.00053544645,0.00036610456,0.00032461743,0.000027206775,0.000051858256,0.000020331607,0.0022967984],"genre_scores_gemma":[0.0034447487,0.9934516,0.0007039746,0.0003048738,0.00021157804,0.000026149793,0.00009154268,0.000003533068,0.0017619426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999176,0.000011503454,0.000007607155,0.000013495397,0.000037940787,0.000011845771],"domain_scores_gemma":[0.999936,0.00001595591,0.000014323507,0.0000022236798,0.000023409426,0.0000081914495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024728756,0.0006290313,0.00094067585,0.0011853159,0.00014367684,0.00042564957,0.00047155446,0.00066643103,0.004034512],"category_scores_gemma":[0.00020385082,0.0001343717,0.00034285762,0.0008068494,0.00022269455,0.00051549193,0.00032107913,0.0010772799,0.0022824437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020283108,0.0002072387,0.00015864681,0.02100733,0.000110680354,0.0004739278,0.000056417754,0.00049993116,0.021541702,0.0031409583,0.025948932,0.92665136],"study_design_scores_gemma":[0.000107540705,0.00047139105,0.0012941884,0.0034927295,0.0001711569,0.0027143282,0.00007070235,0.00030248566,0.0075975233,0.0019325825,0.98181295,0.000032419324],"about_ca_topic_score_codex":0.0005826306,"about_ca_topic_score_gemma":0.0010431902,"teacher_disagreement_score":0.004034512,"about_ca_system_score_codex":0.00032310086,"about_ca_system_score_gemma":0.00047670305,"threshold_uncertainty_score":0.013496816},"labels":[],"label_agreement":null},{"id":"W2098564856","doi":"10.1517/14728222.6.2.159","title":"Tissue factor – a therapeutic target for thrombotic disorders","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Tissue factor; Thromboplastin; Coagulation; Pharmacology; Factor X; Protein C; Cancer research; Immunology; Tissue factor pathway inhibitor; Medicine; Chemistry; Thrombin; Biochemistry; Platelet; Internal medicine","score_opus":0.12248357375745646,"score_gpt":0.39606834235928234,"score_spread":0.2735847686018259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098564856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017511385,0.88896066,0.008469846,0.013345592,0.0071433424,0.0002236757,0.0007342728,0.0003851191,0.06322603],"genre_scores_gemma":[0.18442295,0.69163334,0.0110108955,0.012993315,0.006605262,0.00040147582,0.0017413138,0.00013725036,0.09105413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999835,0.000035109755,0.000010568456,0.000027405482,0.00006673007,0.000025082647],"domain_scores_gemma":[0.9999107,0.000013595442,0.00002028932,0.000006800117,0.000026614825,0.000022058448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034944227,0.0003717409,0.00037295168,0.00048470602,0.0002007565,0.0007347805,0.00031895962,0.000814047,0.009595367],"category_scores_gemma":[0.00031551722,0.00008027641,0.00029459037,0.00027963103,0.0002485382,0.00044837032,0.00032992556,0.0013952685,0.0041233203],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091666204,0.00035233423,0.000544218,0.0027939836,0.00016744551,0.0008915625,0.000112106485,0.00039444945,0.093032986,0.017885689,0.08154229,0.8013663],"study_design_scores_gemma":[0.00023620986,0.0008977284,0.0009017677,0.00042118356,0.00008127485,0.0023620343,0.000026485135,0.0001730528,0.010660412,0.0029729716,0.98125345,0.000013412057],"about_ca_topic_score_codex":0.0002973115,"about_ca_topic_score_gemma":0.0005202995,"teacher_disagreement_score":0.009595367,"about_ca_system_score_codex":0.00035027426,"about_ca_system_score_gemma":0.00034663032,"threshold_uncertainty_score":0.032099664},"labels":[],"label_agreement":null},{"id":"W2101090893","doi":"10.1517/14728222.2015.1042365","title":"Subcellular G-protein coupled receptor signaling hints at greater therapeutic selectivity","year":2015,"lang":"en","type":"editorial","venue":"Expert Opinion on Therapeutic Targets","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; McGill University; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"G protein-coupled receptor; Receptor; Subcellular localization; Cell biology; Signal transduction; Nucleus; Biology; Extracellular; Rhodopsin-like receptors; Cell surface receptor; Intracrine; Transmembrane protein; Cell; Functional selectivity; Cytoplasm; Biochemistry; Agonist; Paracrine signalling","score_opus":0.02336361581227873,"score_gpt":0.2816742498174154,"score_spread":0.25831063400513665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101090893","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036929225,0.12795076,0.0011482912,0.07245971,0.7926989,0.000036016765,0.000116463736,0.00019280233,0.0050278082],"genre_scores_gemma":[0.0052028624,0.13075614,0.0010062814,0.074261546,0.76145893,0.000050995222,0.0001479025,0.00008035938,0.027034987],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832016,0.00034793286,0.00020375401,0.00033196757,0.00065243634,0.00014371722],"domain_scores_gemma":[0.9975746,0.00090433506,0.0001711461,0.00008607735,0.00090673583,0.00035704314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044290884,0.0017794694,0.0014682085,0.0010422072,0.0007452374,0.0030616045,0.0019378305,0.007619407,0.006679003],"category_scores_gemma":[0.0052265576,0.0005239694,0.0011593468,0.00039604193,0.0020413024,0.003173114,0.0013267341,0.013745281,0.005785702],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011553651,0.000024417932,0.00005596713,0.0009766587,0.00004376055,0.0004241817,0.00004152307,0.000097115546,0.0017728849,0.0050302036,0.9514704,0.039947502],"study_design_scores_gemma":[0.00003756355,0.00004364776,0.00013590476,0.00017250814,0.000031913536,0.00036500735,0.0000212563,0.000100748315,0.0005307691,0.0019312683,0.996617,0.0000124652615],"about_ca_topic_score_codex":0.00033269436,"about_ca_topic_score_gemma":0.0009692158,"teacher_disagreement_score":0.007619407,"about_ca_system_score_codex":0.0016662913,"about_ca_system_score_gemma":0.0009109535,"threshold_uncertainty_score":0.023423553},"labels":[],"label_agreement":null},{"id":"W2103071544","doi":"10.1517/14728222.2012.718331","title":"Targeting IL-1 in depression","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Neuroinflammation; Depression (economics); Antidepressant; Anakinra; Inflammation; Medicine; Interleukin; Neurogenesis; Receptor antagonist; Interleukin 6; Cytokine; Internal medicine; Immunology; Pharmacology; Receptor; Antagonist; Psychology; Neuroscience; Hippocampus; Disease","score_opus":0.11416306333005723,"score_gpt":0.37276939465907355,"score_spread":0.25860633132901634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103071544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005564324,0.9705951,0.0005788493,0.018381782,0.0055228886,0.000030817348,0.00015866899,0.000031482577,0.0041439924],"genre_scores_gemma":[0.009018061,0.96759415,0.00056699204,0.012914227,0.0062878802,0.00007956342,0.00019705812,0.000008752006,0.0033332638],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995685,0.00014093753,0.000051247393,0.00006401679,0.00012771584,0.000047596386],"domain_scores_gemma":[0.99931574,0.00028101436,0.0001088058,0.000013364001,0.00023251872,0.000048628863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000726211,0.00042414502,0.0008712079,0.000538675,0.00018013034,0.001166505,0.00089017424,0.0018520807,0.008094278],"category_scores_gemma":[0.0017414627,0.00011754221,0.00067483913,0.00037586316,0.00040909395,0.00085160695,0.0004942038,0.0020653158,0.0035128365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003737162,0.000067455025,0.00031622453,0.02501498,0.000192064,0.00037831784,0.00010544613,0.0002845371,0.003140183,0.0048988773,0.19269717,0.77253103],"study_design_scores_gemma":[0.00017231818,0.00019846833,0.0007824029,0.013082899,0.00025937884,0.0008751957,0.00012545743,0.00021547602,0.00092967553,0.004898637,0.9784344,0.000025611149],"about_ca_topic_score_codex":0.00053590257,"about_ca_topic_score_gemma":0.001074078,"teacher_disagreement_score":0.008094278,"about_ca_system_score_codex":0.0005104447,"about_ca_system_score_gemma":0.0009867784,"threshold_uncertainty_score":0.027078092},"labels":[],"label_agreement":null},{"id":"W2104370773","doi":"10.1517/14728222.2011.561787","title":"Hax-1: a regulator of calcium signaling and apoptosis progression with multiple roles in human disease","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cell biology; Endoplasmic reticulum; Apoptosis; Biology; Inhibitor of apoptosis domain; Calcium signaling; Inhibitor of apoptosis; Signal transduction; Programmed cell death; Caspase; Biochemistry","score_opus":0.043535953456739544,"score_gpt":0.3438346234480893,"score_spread":0.30029866999134974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104370773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00884828,0.9579973,0.002667836,0.008816687,0.004414255,0.00008822882,0.0010304042,0.00027264445,0.015864266],"genre_scores_gemma":[0.06572305,0.89586765,0.0017320589,0.0047373404,0.0048105065,0.00015961185,0.002647726,0.000050049908,0.02427198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998203,0.00002889933,0.0000146461525,0.000041680767,0.00006354013,0.000030916497],"domain_scores_gemma":[0.9998528,0.000019930756,0.00003858151,0.000004372523,0.000049051665,0.000035226523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030028008,0.0005820154,0.0006204921,0.0004560615,0.000308908,0.0010997757,0.0004515686,0.0010388457,0.0069501083],"category_scores_gemma":[0.0002994587,0.00009746655,0.0003264977,0.00047737514,0.00033363642,0.00051465555,0.00061858544,0.001152823,0.0033249883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009062039,0.000081849335,0.0023676911,0.009675816,0.00019438613,0.001224425,0.0002328444,0.0006777234,0.07929367,0.016443465,0.22025643,0.6686455],"study_design_scores_gemma":[0.000071105336,0.00019055832,0.0032769102,0.0008338038,0.00010978751,0.0020463683,0.000098051365,0.00033567863,0.010846903,0.0028618446,0.9793083,0.000020670781],"about_ca_topic_score_codex":0.0003447664,"about_ca_topic_score_gemma":0.00048144662,"teacher_disagreement_score":0.0069501083,"about_ca_system_score_codex":0.00061797025,"about_ca_system_score_gemma":0.0007043103,"threshold_uncertainty_score":0.02325046},"labels":[],"label_agreement":null},{"id":"W2106019293","doi":"10.1517/14728222.2012.665879","title":"Targeting frameshifting in the human immunodeficiency virus","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Frameshift mutation; Translational frameshift; Ribosome; Biology; Cell biology; Genetics; RNA; Gene; Mutation","score_opus":0.07128626624621855,"score_gpt":0.3606875577794025,"score_spread":0.28940129153318395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106019293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013404568,0.99788123,0.00019299229,0.00022816817,0.00026257237,0.0000069386338,0.000014757468,0.000010015138,0.0012692818],"genre_scores_gemma":[0.001193731,0.9969771,0.00026630354,0.00026751927,0.00020050145,0.0000103956345,0.00003714008,0.0000020560472,0.0010453726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983084,0.000025272253,0.000013253154,0.00003164052,0.00007883662,0.000020221696],"domain_scores_gemma":[0.999871,0.000044182827,0.000028629873,0.000003739964,0.000038458344,0.000013966012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046316592,0.00076224195,0.0009957667,0.0010785501,0.00020607951,0.0007088353,0.0008106878,0.001130058,0.0027416812],"category_scores_gemma":[0.00032649367,0.00022247511,0.00033578443,0.0009482706,0.0004421717,0.00081659533,0.00044214324,0.0016968466,0.0027271193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000834625,0.000064506756,0.00010278231,0.015406955,0.000049908416,0.0002924786,0.00004343916,0.000460503,0.007821097,0.004928244,0.03761562,0.9331309],"study_design_scores_gemma":[0.000018030249,0.00011435399,0.0003926479,0.0018870436,0.00005455084,0.0014059298,0.00002578584,0.00010900751,0.0018461908,0.0014775139,0.9926536,0.000015296322],"about_ca_topic_score_codex":0.0008250079,"about_ca_topic_score_gemma":0.0012542856,"teacher_disagreement_score":0.0027416812,"about_ca_system_score_codex":0.000732198,"about_ca_system_score_gemma":0.00058635697,"threshold_uncertainty_score":0.009171903},"labels":[],"label_agreement":null},{"id":"W2107857520","doi":"10.1517/14728222.11.2.161","title":"Targeting acetylcholinesterase to treat neurodegeneration","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Acetylcholinesterase; Acetylcholine; Cholinergic; Neurodegeneration; Pharmacology; Alzheimer's disease; Disease; Medicine; Neuroscience; Aché; Cholinesterase; Muscarinic acetylcholine receptor; Chemistry; Internal medicine; Biology; Biochemistry; Enzyme; Receptor","score_opus":0.15642265201261588,"score_gpt":0.4447747027527863,"score_spread":0.28835205074017045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107857520","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010028746,0.99100566,0.0011499204,0.00053664093,0.00045023457,0.000033982098,0.000032231554,0.000038868147,0.005749465],"genre_scores_gemma":[0.0033538872,0.99078304,0.0011294116,0.00054411835,0.00022151196,0.00003742334,0.000079663274,0.0000051200227,0.0038458356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989235,0.000016287679,0.000008363822,0.00001832627,0.00005028157,0.000014435176],"domain_scores_gemma":[0.9999449,0.000013568991,0.000010294519,0.0000024155834,0.000019955,0.000008966451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003868492,0.00095819647,0.0013126307,0.0014798583,0.00021583971,0.0005261284,0.0007780627,0.0010926432,0.005036343],"category_scores_gemma":[0.00017158463,0.00018372064,0.00034029357,0.0009707323,0.0003177432,0.0006451849,0.0004297833,0.0013079902,0.004651437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012872425,0.00025741034,0.00012141497,0.009214997,0.00011757196,0.00080767705,0.00008823799,0.00065445364,0.03247524,0.004318622,0.03200149,0.9198141],"study_design_scores_gemma":[0.00010475361,0.0003725463,0.00077752233,0.0014645419,0.00010791355,0.0026403598,0.000056921028,0.00028581198,0.0053345403,0.0021795884,0.9866545,0.0000209048],"about_ca_topic_score_codex":0.0008700171,"about_ca_topic_score_gemma":0.0016746864,"teacher_disagreement_score":0.005036343,"about_ca_system_score_codex":0.00047039508,"about_ca_system_score_gemma":0.0004999702,"threshold_uncertainty_score":0.016848266},"labels":[],"label_agreement":null},{"id":"W2112130045","doi":"10.1517/14728222.12.2.209","title":"Mammalian target of rapamycin as a therapeutic target in oncology","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pearl; Oncology; Clinical Oncology; Internal medicine; Medicine; Geography; Cancer; Archaeology","score_opus":0.05541256095740467,"score_gpt":0.38230976146342105,"score_spread":0.3268972005060164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112130045","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020039163,0.99499714,0.0004046127,0.0009042869,0.0005365815,0.00000800197,0.000011426112,0.000017076974,0.0029204953],"genre_scores_gemma":[0.0016664849,0.9947902,0.0007146597,0.00073560677,0.0005529366,0.000015912587,0.000033722852,0.0000035123899,0.0014870162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997706,0.00005475208,0.000024820598,0.000036158486,0.000092679584,0.00002095177],"domain_scores_gemma":[0.99983525,0.00006227412,0.000029803294,0.0000073708547,0.000044358865,0.000020978998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060704694,0.00091344496,0.0013839126,0.0014885936,0.0002840821,0.000870183,0.0008663004,0.0017739478,0.0037534838],"category_scores_gemma":[0.00037437995,0.00022062278,0.000362907,0.001682917,0.0006525534,0.0012449044,0.00047554413,0.0021202203,0.0047757276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009769535,0.00008681666,0.000109195316,0.0069140154,0.000051943487,0.00062985823,0.000048663198,0.0005292584,0.0068177576,0.0077592563,0.037173014,0.9397826],"study_design_scores_gemma":[0.00003483171,0.00014090064,0.00042999137,0.0012260979,0.000053759562,0.003384795,0.00004102566,0.00015832686,0.0015059193,0.0036994969,0.9893077,0.000017234497],"about_ca_topic_score_codex":0.00041781712,"about_ca_topic_score_gemma":0.0007336547,"teacher_disagreement_score":0.0037534838,"about_ca_system_score_codex":0.0007261636,"about_ca_system_score_gemma":0.00085188326,"threshold_uncertainty_score":0.012556672},"labels":[],"label_agreement":null},{"id":"W2115365563","doi":"10.1517/14728222.7.2.249","title":"When the DREAM is gone:from basic science to future prospectives in pain management and beyond","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Dynorphin; Dream; Transcription factor; Repressor; Neuroscience; Biology; Cell biology; Gene; Opioid peptide; Opioid; Genetics; Receptor","score_opus":0.037462084973372646,"score_gpt":0.34152721449809936,"score_spread":0.3040651295247267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115365563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001110078,0.99593544,0.00018635129,0.0021750247,0.00046365077,0.0000035910762,0.000007982681,0.000006295381,0.0011106271],"genre_scores_gemma":[0.001075831,0.995443,0.0004255751,0.0012159824,0.00050972763,0.000010454125,0.000016566208,0.0000024176609,0.0013005668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997477,0.00008284475,0.000035268567,0.000027693022,0.0000751727,0.000031247262],"domain_scores_gemma":[0.9997323,0.00012431714,0.00003516566,0.0000087424705,0.00006334197,0.00003621874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010982602,0.0007814115,0.0017162045,0.0012014529,0.00050718844,0.0015605794,0.0011615012,0.0020867237,0.0048034685],"category_scores_gemma":[0.00070633256,0.00025791838,0.00041114888,0.0011838435,0.0011441109,0.0032944055,0.0007995478,0.002655074,0.003267973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021474961,0.00009441618,0.00019124722,0.013054509,0.000077478806,0.0008433589,0.00028673874,0.0002924226,0.0030287495,0.011849244,0.056121696,0.91394544],"study_design_scores_gemma":[0.00006501516,0.00021473377,0.00061714416,0.004834815,0.00006840022,0.0031479755,0.00078647165,0.00012746661,0.0005965971,0.015570282,0.9739358,0.000035204048],"about_ca_topic_score_codex":0.0010852173,"about_ca_topic_score_gemma":0.0030703782,"teacher_disagreement_score":0.0048034685,"about_ca_system_score_codex":0.0011801572,"about_ca_system_score_gemma":0.0014242383,"threshold_uncertainty_score":0.016069233},"labels":[],"label_agreement":null},{"id":"W2116344367","doi":"10.1517/14728222.2010.531014","title":"Paving the way for targeting RSK in cancer","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Kinase; Ribosomal s6 kinase; MAPK/ERK pathway; Biology; Cell biology; Motility; Cancer cell; Cancer; Signal transduction; Phosphorylation; Cell growth; Protein kinase A; p38 mitogen-activated protein kinases; Cancer research; PI3K/AKT/mTOR pathway; Biochemistry; Genetics; P70-S6 Kinase 1","score_opus":0.02663451962857396,"score_gpt":0.31911428966363176,"score_spread":0.2924797700350578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116344367","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047681175,0.8188811,0.033478517,0.06881848,0.003547285,0.0002754012,0.00031609688,0.00059262034,0.026409471],"genre_scores_gemma":[0.1898826,0.74166054,0.030086625,0.015816279,0.0029146862,0.00029366824,0.0004376172,0.000081995735,0.018825924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997979,0.00006720517,0.000013907469,0.000028124472,0.00004392061,0.000048934406],"domain_scores_gemma":[0.9998666,0.000040149564,0.000020595957,0.000009648335,0.000027812619,0.00003516327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070777786,0.0005319881,0.00069256313,0.0004789805,0.00035033506,0.0010222899,0.0006156344,0.001870084,0.0042698137],"category_scores_gemma":[0.00030999488,0.0002601118,0.00043015834,0.00035733974,0.0007247018,0.0016738048,0.000590319,0.0021413432,0.00199711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012277951,0.00063906243,0.0012533683,0.003877709,0.00013393929,0.002214296,0.0002867751,0.0038030515,0.21059068,0.034371153,0.05447247,0.6871297],"study_design_scores_gemma":[0.0005876507,0.001859485,0.0023929994,0.0005080162,0.0001699348,0.004193451,0.0003541394,0.0033287553,0.060629115,0.033189226,0.89270455,0.00008270248],"about_ca_topic_score_codex":0.0005366944,"about_ca_topic_score_gemma":0.0015521736,"teacher_disagreement_score":0.0042698137,"about_ca_system_score_codex":0.0007507342,"about_ca_system_score_gemma":0.000798227,"threshold_uncertainty_score":0.014283955},"labels":[],"label_agreement":null},{"id":"W2118534575","doi":"10.1517/14728222.12.1.59","title":"Targeting synuclein-γ to counteract drug resistance in cancer","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Synuclein; Medicine; Cancer research; Breast cancer; Cancer; Internal medicine; Oncology; Disease; Alpha-synuclein; Parkinson's disease","score_opus":0.07792850072708807,"score_gpt":0.41458467241393715,"score_spread":0.3366561716868491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118534575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001593968,0.9943328,0.00055087847,0.00044907696,0.00020858023,0.000025518533,0.00003472861,0.00003030262,0.002774201],"genre_scores_gemma":[0.006977155,0.98901075,0.001095976,0.00043340033,0.00017621487,0.000034230896,0.00007143972,0.000004185257,0.0021966237],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991083,0.00001837209,0.000009995954,0.000013165272,0.000036163838,0.000011473979],"domain_scores_gemma":[0.99993074,0.000020947491,0.00001881342,0.0000020971288,0.000019163872,0.000008167537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032269975,0.00066939194,0.0011159983,0.0011654056,0.0001725533,0.00048577593,0.0006368771,0.0010026108,0.0027762135],"category_scores_gemma":[0.00016524197,0.00016533828,0.00033220625,0.00074601016,0.00020073411,0.00044092076,0.0002580785,0.00081139646,0.0024134906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023948481,0.00026590764,0.00028686205,0.013363436,0.00017450993,0.0010690239,0.00008028448,0.00094162556,0.035086893,0.0031711622,0.02110562,0.9242152],"study_design_scores_gemma":[0.0002694171,0.0009938101,0.0022310936,0.0027305563,0.00027017482,0.0052334866,0.00009978982,0.0006355558,0.012656134,0.002761533,0.9720825,0.000036005382],"about_ca_topic_score_codex":0.00049236347,"about_ca_topic_score_gemma":0.0013028211,"teacher_disagreement_score":0.0027762135,"about_ca_system_score_codex":0.00040161135,"about_ca_system_score_gemma":0.00033927656,"threshold_uncertainty_score":0.009287357},"labels":[],"label_agreement":null},{"id":"W2120485507","doi":"10.1517/14728222.2014.915315","title":"Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Triple-negative breast cancer; Breast cancer; Medicine; Cancer; Cancer research; Carcinogenesis; Targeted therapy; Bioinformatics; Oncology; Internal medicine; Biology","score_opus":0.028072617608273696,"score_gpt":0.33658227045227634,"score_spread":0.30850965284400267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120485507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015898193,0.99688196,0.00020036782,0.00083366776,0.00048859225,0.000006426805,0.000020745467,0.000010326753,0.0013989363],"genre_scores_gemma":[0.0010170103,0.9965597,0.00021509823,0.00056621345,0.00039331426,0.000008805748,0.00003566627,0.000001894963,0.0012022963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988604,0.000018688834,0.000009651403,0.00001940494,0.00005175115,0.000014467997],"domain_scores_gemma":[0.9998658,0.000045881203,0.000022378183,0.0000027188703,0.00004516953,0.000018085335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038771852,0.00055662735,0.0007334376,0.00095701806,0.00018683689,0.00062660343,0.00059254083,0.0010730012,0.0032159265],"category_scores_gemma":[0.00038628705,0.00016153995,0.0003373012,0.000911362,0.00028487298,0.0008212849,0.00043849912,0.0016983488,0.002621532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008052694,0.00004572892,0.00009979946,0.008216968,0.000053182837,0.00022929905,0.000031905216,0.0003448278,0.0035243381,0.0033806732,0.05563103,0.92836165],"study_design_scores_gemma":[0.00002432335,0.00009849369,0.00045260845,0.0019878324,0.000057760044,0.0011216908,0.00003181252,0.00014130978,0.00070225564,0.0019391767,0.99342924,0.00001337012],"about_ca_topic_score_codex":0.000644526,"about_ca_topic_score_gemma":0.0016091242,"teacher_disagreement_score":0.0032159265,"about_ca_system_score_codex":0.0006268979,"about_ca_system_score_gemma":0.0006354074,"threshold_uncertainty_score":0.0107584},"labels":[],"label_agreement":null},{"id":"W2121138686","doi":"10.1517/14728220903454988","title":"<i>Pseudomonas aeruginosa</i>biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Pseudomonas aeruginosa; Cystic fibrosis; Biofilm; Microbiology; Mucus; Airway; Antibiotics; Immune system; Immunology; Organism; Biology; Medicine; Bacteria; Internal medicine","score_opus":0.039603045164154124,"score_gpt":0.3693162186729152,"score_spread":0.32971317350876106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121138686","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000088501496,0.99586666,0.0001500635,0.001467109,0.00083359383,0.000006993947,0.000015311787,0.000011405905,0.0015603658],"genre_scores_gemma":[0.00053898885,0.99592173,0.00025029585,0.00078074745,0.0008892426,0.0000093048975,0.000027779502,0.0000020869707,0.0015798184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998215,0.000034401783,0.00001666639,0.000020378824,0.00008643948,0.000020626772],"domain_scores_gemma":[0.9997049,0.00011567197,0.000035026165,0.000008739239,0.00009521026,0.000040354527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005725027,0.00077683205,0.0011192322,0.0013439691,0.0002623356,0.0006890919,0.00069437135,0.0016541422,0.004446247],"category_scores_gemma":[0.0006621157,0.00017151871,0.00038217803,0.0012591382,0.00046941056,0.0015018965,0.0005316181,0.0020337095,0.003719653],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009646768,0.00006472402,0.000117131916,0.008731805,0.000040323812,0.0002656503,0.000080675054,0.0003187442,0.0034954245,0.0031644534,0.15643395,0.8271907],"study_design_scores_gemma":[0.00002709723,0.00013103985,0.0007926293,0.003277992,0.00003645118,0.0012210505,0.00007272976,0.00012912962,0.00049019436,0.0020418866,0.99176484,0.0000149706075],"about_ca_topic_score_codex":0.0013581967,"about_ca_topic_score_gemma":0.0024162324,"teacher_disagreement_score":0.004446247,"about_ca_system_score_codex":0.0006750256,"about_ca_system_score_gemma":0.00080850493,"threshold_uncertainty_score":0.01487416},"labels":[],"label_agreement":null},{"id":"W2122998269","doi":"10.1517/14728222.11.6.733","title":"The role of vasoactive intestinal peptide in neuroprotection: interview with Professor Illana Gozes","year":2007,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Anesthesia and Neurotoxicity Research","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Editorial board; Library science; Editor in chief; Tel aviv; Management; Medicine","score_opus":0.05300640129291022,"score_gpt":0.33331886224312557,"score_spread":0.28031246095021534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122998269","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006255331,0.035188332,0.00017102186,0.94659615,0.016225591,0.000018117447,0.000023473238,0.000016850172,0.001134945],"genre_scores_gemma":[0.009351214,0.030879721,0.00054701767,0.9099287,0.042414896,0.00008703539,0.00003167754,0.000027385388,0.006732367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978781,0.0009478008,0.00017658371,0.0002787914,0.00047062995,0.0002481917],"domain_scores_gemma":[0.9938035,0.0029018798,0.0003852591,0.00008135977,0.0016699586,0.0011580192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065849256,0.0006806795,0.0011833344,0.00081631244,0.001929416,0.0024540212,0.0014811286,0.010079338,0.0029408603],"category_scores_gemma":[0.014904472,0.00042034636,0.00075172854,0.0007321851,0.0020217241,0.0047200555,0.002120648,0.017725993,0.0010572326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059021786,0.000027997447,0.00047264915,0.00018988001,0.000012470478,0.00072892365,0.0010705333,0.00007722452,0.00020631182,0.0014934485,0.9722386,0.023422942],"study_design_scores_gemma":[0.00005320877,0.0001309989,0.0009962075,0.0005603026,0.000025073976,0.003567587,0.0029937516,0.00012791513,0.00020305632,0.0017797815,0.9895063,0.00005589057],"about_ca_topic_score_codex":0.0047035483,"about_ca_topic_score_gemma":0.0056320624,"teacher_disagreement_score":0.010079338,"about_ca_system_score_codex":0.0039209644,"about_ca_system_score_gemma":0.003816526,"threshold_uncertainty_score":0.03482485},"labels":[],"label_agreement":null},{"id":"W2123573411","doi":"10.1517/14728222.2014.920326","title":"Lipoprotein(a) as a therapeutic target in cardiovascular disease","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Canadian Institutes of Health Research","keywords":"Disease; Medicine; Lipoprotein; Atherosclerotic cardiovascular disease; Bioinformatics; Pharmacology; Cholesterol; Intensive care medicine; Internal medicine; Biology","score_opus":0.049954008884343266,"score_gpt":0.35039131917059474,"score_spread":0.3004373102862515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123573411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054744785,0.9973349,0.000104084495,0.0011119851,0.00047777905,0.0000043544883,0.000017296668,0.0000069171065,0.00088794075],"genre_scores_gemma":[0.00055783003,0.9978835,0.0001401474,0.0005446798,0.00038293895,0.0000067316055,0.000023734809,0.000001387313,0.00045898822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966943,0.00007780592,0.000037694736,0.000051850388,0.00013381135,0.000029460965],"domain_scores_gemma":[0.9995553,0.0001867258,0.00006133873,0.00001264264,0.00014719577,0.00003674374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000798787,0.0007464528,0.0014545629,0.0013854819,0.0002705426,0.0010595472,0.0008698472,0.0018825164,0.0055575967],"category_scores_gemma":[0.0011054828,0.00019326256,0.0005786025,0.0015130528,0.0004815205,0.0012161471,0.00068455876,0.002630683,0.0041881963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000904371,0.000054888507,0.00010989229,0.019871151,0.0001352214,0.0001590495,0.000052339128,0.0002910547,0.0013195573,0.005938923,0.072046585,0.8999309],"study_design_scores_gemma":[0.000030897736,0.00007636892,0.00043149904,0.00630674,0.0001151645,0.00066872267,0.00005021668,0.0001089418,0.00027010686,0.0031176058,0.98880696,0.000016669923],"about_ca_topic_score_codex":0.0008802594,"about_ca_topic_score_gemma":0.0012497647,"teacher_disagreement_score":0.0055575967,"about_ca_system_score_codex":0.0006363525,"about_ca_system_score_gemma":0.001238671,"threshold_uncertainty_score":0.018592},"labels":[],"label_agreement":null},{"id":"W2131003727","doi":"10.1517/14728222.6.2.203","title":"Identification of new therapeutic targets for prevention of CNS inflammation","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Microglia; Immunology; Tumor necrosis factor alpha; Multiple sclerosis; Inflammation; Central nervous system; Receptor; Nitric oxide; Biology; CD8; Interferon gamma; Cell biology; Cytokine; Immune system; Neuroscience; Endocrinology; Biochemistry","score_opus":0.1540337572631458,"score_gpt":0.382855082744361,"score_spread":0.22882132548121517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131003727","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001276119,0.9890042,0.0016859365,0.0016624742,0.0006476784,0.000037427115,0.00005086797,0.00005906283,0.005576246],"genre_scores_gemma":[0.005749194,0.98536783,0.0026760774,0.001193539,0.0005980654,0.000075042924,0.00014607077,0.000011298885,0.004182835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998216,0.00004542331,0.00001431866,0.00003196014,0.00005999961,0.00002680553],"domain_scores_gemma":[0.99987245,0.000038915892,0.00001918168,0.000008514287,0.000038319715,0.000022672913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006689382,0.0010876128,0.0019702418,0.0014479733,0.000281357,0.00091657613,0.0011717561,0.0015953036,0.0072457925],"category_scores_gemma":[0.00032692633,0.00020266883,0.00038101923,0.0009933435,0.0005662455,0.0012195946,0.0005019593,0.0017119201,0.004794398],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002225749,0.00033586725,0.00018238612,0.0067031225,0.00009232809,0.00068196893,0.000077109755,0.0007288084,0.01710167,0.0069531812,0.027469292,0.93945163],"study_design_scores_gemma":[0.00018554306,0.0005200628,0.0011193713,0.001555602,0.000114749935,0.0026912761,0.00010758479,0.0003883836,0.0050622663,0.005859205,0.98236716,0.00002871009],"about_ca_topic_score_codex":0.00038957284,"about_ca_topic_score_gemma":0.0010294685,"teacher_disagreement_score":0.0072457925,"about_ca_system_score_codex":0.00063210557,"about_ca_system_score_gemma":0.0006069422,"threshold_uncertainty_score":0.02423954},"labels":[],"label_agreement":null},{"id":"W2143053439","doi":"10.1517/14728222.12.6.717","title":"The paraventricular nucleus of the hypothalamus – a potential target for integrative treatment of autonomic dysfunction","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Neuroscience of respiration and sleep","field":"Neuroscience","cited_by":319,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Hypothalamus; Neuroscience; Nucleus; Afferent; Medicine; Heart failure; Median preoptic nucleus; Subfornical organ; Autonomic nervous system; Glutamate receptor; Biology; Internal medicine; Angiotensin II; Heart rate; Blood pressure; Receptor","score_opus":0.0776118878994255,"score_gpt":0.3412326497276831,"score_spread":0.26362076182825755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143053439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006391325,0.9930453,0.00082518085,0.0013603738,0.00068067166,0.000012891336,0.000020187754,0.000022753138,0.0033935397],"genre_scores_gemma":[0.0057039196,0.98848736,0.0015695962,0.00076042616,0.0007196251,0.000027072334,0.000053788957,0.00000554098,0.00267275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999312,0.000017375467,0.0000060332945,0.000012058382,0.00002451902,0.000008658531],"domain_scores_gemma":[0.9999378,0.000021814343,0.000010837457,0.000002901359,0.00001682293,0.000009819534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033043677,0.0005265825,0.00078966655,0.0005669146,0.00015387152,0.00038970713,0.000703128,0.00088410545,0.0035758314],"category_scores_gemma":[0.00018156087,0.00008864697,0.00027261738,0.00036381738,0.00032566427,0.000577908,0.00029883068,0.0012951838,0.0017185915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018830504,0.00015921138,0.00022946716,0.0062988456,0.00009706406,0.00072173,0.000052375315,0.000549196,0.014396559,0.0058369357,0.03156459,0.93990564],"study_design_scores_gemma":[0.00016497183,0.00046937872,0.0025826755,0.002167688,0.0001223676,0.004051028,0.000111380956,0.00039202994,0.0035904923,0.0061069285,0.9802115,0.000029629204],"about_ca_topic_score_codex":0.00040566525,"about_ca_topic_score_gemma":0.0011141028,"teacher_disagreement_score":0.0035758314,"about_ca_system_score_codex":0.00032644015,"about_ca_system_score_gemma":0.00048425698,"threshold_uncertainty_score":0.011962354},"labels":[],"label_agreement":null},{"id":"W2144427044","doi":"10.1517/14728222.2014.938052","title":"DNMTs as potential therapeutic targets in high-risk pediatric embryonal brain tumors","year":2014,"lang":"en","type":"editorial","venue":"Expert Opinion on Therapeutic Targets","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Epigenetics; DNA methylation; Biology; Phenotype; Epigenomics; Brain tumor; Cancer research; Gene silencing; Methyltransferase; Bioinformatics; Gene; Methylation; Genetics; Pathology; Gene expression; Medicine","score_opus":0.007785674253456142,"score_gpt":0.27958923293392773,"score_spread":0.27180355868047157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144427044","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068562577,0.32925892,0.0013339213,0.08648362,0.5774149,0.00007209285,0.00012642775,0.0001658685,0.004458719],"genre_scores_gemma":[0.0045629865,0.27824962,0.0012806052,0.058684334,0.6354937,0.000103873586,0.00012884187,0.00005668953,0.021439392],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999223,0.0001549053,0.00012109614,0.0001190299,0.00031575793,0.00006618658],"domain_scores_gemma":[0.99881846,0.0004917966,0.00010601969,0.00002665684,0.00038930945,0.00016773336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022048214,0.0016302125,0.0013679588,0.0007633723,0.00054934045,0.0016091075,0.0017230569,0.006230063,0.0023306746],"category_scores_gemma":[0.0028740515,0.000474671,0.0009985298,0.00045408448,0.0009258616,0.0020171143,0.0006759891,0.010717322,0.002036643],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016761514,0.000045526187,0.00006784365,0.0010171396,0.00005698197,0.00044410693,0.00003596791,0.00020882931,0.0015067047,0.0021987571,0.9169151,0.07733542],"study_design_scores_gemma":[0.000085419335,0.000083403604,0.00024207695,0.00030968167,0.000051922074,0.00057915715,0.000022264823,0.0002358193,0.0005645004,0.001336294,0.9964748,0.00001471208],"about_ca_topic_score_codex":0.00050060876,"about_ca_topic_score_gemma":0.0016127442,"teacher_disagreement_score":0.006230063,"about_ca_system_score_codex":0.0014771178,"about_ca_system_score_gemma":0.0008271048,"threshold_uncertainty_score":0.011660337},"labels":[],"label_agreement":null},{"id":"W2145633869","doi":"10.1517/14728222.10.5.777","title":"Novel targets in prostate cancer","year":2006,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Prostate cancer; Medicine; Context (archaeology); Sorafenib; Prostate; Cancer; Disease; Oncology; Internal medicine; Cancer research; Bioinformatics; Biology","score_opus":0.040874257755146005,"score_gpt":0.35918908279755435,"score_spread":0.3183148250424083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145633869","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044668615,0.9528887,0.0025613282,0.017296258,0.0034940767,0.000058605183,0.000121534475,0.00007559321,0.019037127],"genre_scores_gemma":[0.058994334,0.9038326,0.004576946,0.009070057,0.00408505,0.00012327798,0.00030233117,0.000025348932,0.018989997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971837,0.00007705445,0.000014468978,0.000042658095,0.00010236523,0.000045072687],"domain_scores_gemma":[0.9998541,0.000047353868,0.000016950593,0.000008298266,0.00003994504,0.000033344244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007338959,0.00048623985,0.00075657526,0.0007960969,0.00035319288,0.0010111791,0.00050212897,0.0013700147,0.00679136],"category_scores_gemma":[0.00040142573,0.00015175277,0.00033712198,0.00058093935,0.00041585218,0.0008483325,0.0005446642,0.0016956999,0.0025720336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039193075,0.00028479964,0.00056985987,0.0042048953,0.00009937437,0.0019330025,0.00022712293,0.00087856245,0.029474478,0.04237582,0.09980238,0.8197578],"study_design_scores_gemma":[0.00019606606,0.0005255097,0.0012208334,0.0005644225,0.000057912926,0.003447572,0.00011866291,0.00048762342,0.0066516907,0.016223026,0.9704828,0.000023797242],"about_ca_topic_score_codex":0.00039932402,"about_ca_topic_score_gemma":0.0012747633,"teacher_disagreement_score":0.00679136,"about_ca_system_score_codex":0.00091977936,"about_ca_system_score_gemma":0.0004617603,"threshold_uncertainty_score":0.022719324},"labels":[],"label_agreement":null},{"id":"W2151900613","doi":"10.1517/14728222.10.4.533","title":"Targeting invading macrophage- derived PGE<sub>2</sub>, IL-6 and calcitonin gene-related peptide in injured nerve to treat neuropathic pain","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"Canadian Institutes of Health Research","keywords":"Neuropathic pain; Medicine; Nerve injury; Dorsal root ganglion; Nociceptor; Downregulation and upregulation; Calcitonin gene-related peptide; Nociception; Neuroscience; Inflammation; Calcitonin; Immunology; Pharmacology; Neuropeptide; Anesthesia; Internal medicine; Receptor; Biology; Anatomy; Dorsum","score_opus":0.03642749677400548,"score_gpt":0.32260902211144105,"score_spread":0.28618152533743557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151900613","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003569064,0.98548555,0.0019577793,0.00081803533,0.00061162293,0.00006253412,0.00005099522,0.000040812596,0.007403596],"genre_scores_gemma":[0.010722402,0.9765396,0.003313923,0.00081897626,0.00036151835,0.00007601395,0.00011182868,0.00000962812,0.008046054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998876,0.000019853102,0.00001071017,0.000014218198,0.000051763716,0.000015835398],"domain_scores_gemma":[0.9999418,0.00001429342,0.00001407319,0.0000021813485,0.000018079918,0.000009519182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030318173,0.00083591265,0.0011972215,0.0011515454,0.00019776533,0.0005406703,0.0006534729,0.0010169791,0.0045696218],"category_scores_gemma":[0.00018069871,0.00015049765,0.0003092401,0.0006776746,0.00026184658,0.0006936289,0.00027698086,0.0006980048,0.0035902727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029307834,0.00030315478,0.00020278286,0.012112218,0.00010607026,0.0016524498,0.00010679732,0.0006311462,0.073961444,0.0035890879,0.018475173,0.8885667],"study_design_scores_gemma":[0.0002542874,0.0010534293,0.0016374723,0.0019644722,0.00022142884,0.0069902837,0.00019188672,0.00041082688,0.028459633,0.0028131567,0.9559627,0.000040325533],"about_ca_topic_score_codex":0.00048603342,"about_ca_topic_score_gemma":0.0012204575,"teacher_disagreement_score":0.0045696218,"about_ca_system_score_codex":0.00037662336,"about_ca_system_score_gemma":0.0004711382,"threshold_uncertainty_score":0.015286922},"labels":[],"label_agreement":null},{"id":"W2155473026","doi":"10.1517/14728222.2010.487866","title":"Gap junctions and connexins as therapeutic targets in cancer","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Connexin; Gap junction; Bystander effect; Cancer; Biology; Cancer cell; Metastasis; Cell biology; Neuroscience; Cancer research; Intracellular; Immunology; Genetics","score_opus":0.06742477997633876,"score_gpt":0.38578397060782543,"score_spread":0.31835919063148665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155473026","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011777226,0.9976186,0.00021228848,0.00059419306,0.00034986518,0.000004450655,0.0000065885715,0.0000075767634,0.0010886582],"genre_scores_gemma":[0.0005891267,0.99770516,0.0002759669,0.00026802806,0.00029545068,0.0000074868276,0.000013715769,0.0000017372956,0.0008433806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998116,0.00004394974,0.000019990126,0.000027694632,0.0000799698,0.000016757931],"domain_scores_gemma":[0.9998203,0.00007834846,0.000023052402,0.000007935259,0.000047802412,0.00002261291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052749604,0.0007948618,0.0011833175,0.0014904127,0.00032636014,0.00071736355,0.0007271899,0.0015786979,0.0034332632],"category_scores_gemma":[0.00042571776,0.00019996846,0.00036091037,0.0014892061,0.00062972435,0.0016680841,0.0006029024,0.001994312,0.0028950048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070391245,0.00008452767,0.000109060275,0.009874797,0.000056664125,0.00047587013,0.000095022886,0.0006110966,0.0061591305,0.010019088,0.04388384,0.9285605],"study_design_scores_gemma":[0.000017892564,0.00010237037,0.000541736,0.0017604812,0.000040480256,0.0022930847,0.00007747998,0.000118673706,0.00094325864,0.004515634,0.9895723,0.000016648859],"about_ca_topic_score_codex":0.000648085,"about_ca_topic_score_gemma":0.0012033072,"teacher_disagreement_score":0.0034332632,"about_ca_system_score_codex":0.00071086275,"about_ca_system_score_gemma":0.00078216917,"threshold_uncertainty_score":0.011485398},"labels":[],"label_agreement":null},{"id":"W2156788906","doi":"10.1517/14728222.12.10.1265","title":"Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"GSK-3; Glycogen synthase; Regulator; Diabetes mellitus; Enzyme; Type 2 diabetes; Biology; Glycogen; Insulin resistance; GSK3B; Glucose homeostasis; Kinase; Cell biology; Pharmacology; Biochemistry; Chemistry; Endocrinology; Gene","score_opus":0.05179947035749451,"score_gpt":0.33786220533901995,"score_spread":0.28606273498152546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156788906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071042276,0.9953172,0.00060078443,0.0007642609,0.00046649526,0.000013931498,0.000031492338,0.000024921586,0.0020705776],"genre_scores_gemma":[0.0025583652,0.99451905,0.00071217783,0.00040804813,0.00026614981,0.000019477127,0.000058143138,0.0000030906028,0.0014555636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998983,0.000018787905,0.000012447558,0.00001599811,0.000043504253,0.000010943838],"domain_scores_gemma":[0.99992335,0.000024685245,0.000016876118,0.0000023079183,0.000020761345,0.000011942902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039983884,0.0006517174,0.0010918841,0.0011041026,0.00013883642,0.00045146403,0.0007439793,0.0009094852,0.0026914799],"category_scores_gemma":[0.00022511135,0.00013356819,0.0003165235,0.0008735612,0.0002645537,0.00053822563,0.0003250411,0.0011116777,0.0025631713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018562037,0.00009578311,0.00015004598,0.0066753086,0.00010628748,0.000716745,0.000035922538,0.00050666265,0.009211113,0.002383507,0.031847756,0.94808525],"study_design_scores_gemma":[0.0001862714,0.0003620769,0.0014256143,0.0020642586,0.00021135574,0.004282625,0.00006927554,0.00033703525,0.0032815596,0.0026381554,0.9851104,0.000031304033],"about_ca_topic_score_codex":0.00060183136,"about_ca_topic_score_gemma":0.0015579959,"teacher_disagreement_score":0.0026914799,"about_ca_system_score_codex":0.0004352595,"about_ca_system_score_gemma":0.00046078968,"threshold_uncertainty_score":0.009003878},"labels":[],"label_agreement":null},{"id":"W2162845412","doi":"10.1517/14728222.11.10.1339","title":"c-Jun N-terminal kinases as potential therapeutic targets","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of Otago","keywords":"Kinase; Disease; Signal transduction; Inflammation; Pathogenesis; p38 mitogen-activated protein kinases; Diabetes mellitus; c-jun; Cancer; Bioinformatics; Medicine; Immunology; Biology; Cancer research; Neuroscience; Cell biology; Gene; Protein kinase A; Genetics; Transcription factor; Pathology; Endocrinology","score_opus":0.0574021792479626,"score_gpt":0.36577426696190085,"score_spread":0.30837208771393826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162845412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020168432,0.99650747,0.00024703247,0.0006140304,0.00043583094,0.000009705777,0.00001872521,0.000014544512,0.0019510043],"genre_scores_gemma":[0.0011060791,0.9958003,0.00044638963,0.00054453814,0.00035631924,0.00002071359,0.000057827387,0.000002776882,0.0016650507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998266,0.000033075776,0.000015989519,0.000029567442,0.000070134425,0.000024747485],"domain_scores_gemma":[0.99981576,0.00007111308,0.000026380132,0.000006517645,0.000055178054,0.00002515494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070811086,0.0010499661,0.0015850624,0.0015067455,0.00025882194,0.00090359786,0.0011303697,0.0015370717,0.0042560236],"category_scores_gemma":[0.0004475656,0.00028733912,0.00045171217,0.0012708555,0.0004665609,0.0013742801,0.00057484396,0.0029745672,0.004455614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018638949,0.00019134606,0.00012884266,0.008281086,0.00007797223,0.0005450453,0.000049450933,0.0006596115,0.007713842,0.0059333285,0.059861694,0.91637146],"study_design_scores_gemma":[0.00008153555,0.00013709531,0.00047402713,0.0013296055,0.00006122068,0.0014665481,0.00003980018,0.00018343034,0.0012540343,0.0026799128,0.99227226,0.000020659936],"about_ca_topic_score_codex":0.00046376674,"about_ca_topic_score_gemma":0.0013724008,"teacher_disagreement_score":0.0042560236,"about_ca_system_score_codex":0.000688261,"about_ca_system_score_gemma":0.00060584355,"threshold_uncertainty_score":0.0142377615},"labels":[],"label_agreement":null},{"id":"W2166861359","doi":"10.1517/14728222.10.2.289","title":"The emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisation","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Computational biology; Personalized medicine; Drug; Drug discovery; Biology; Human genome; Precision medicine; Single-nucleotide polymorphism; Bioinformatics; Gene; Genome; Pharmacology; Genetics","score_opus":0.08813478646019927,"score_gpt":0.40229858041891026,"score_spread":0.31416379395871097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166861359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030153606,0.87371016,0.05567742,0.04417102,0.0069511216,0.000092687624,0.00034036353,0.00048188563,0.0155599695],"genre_scores_gemma":[0.018629994,0.9000475,0.042126853,0.016786467,0.008490866,0.00014581844,0.0005204625,0.00012893419,0.013123109],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976979,0.00062053796,0.00009631142,0.00040130335,0.0010489104,0.00013501706],"domain_scores_gemma":[0.9971802,0.001289033,0.0003760177,0.00021227513,0.00075617066,0.00018630132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033698282,0.00095441204,0.001612252,0.0022017488,0.00033577945,0.0029376866,0.0016799835,0.004724668,0.00412268],"category_scores_gemma":[0.00237478,0.0004978525,0.00092429086,0.0016175421,0.0020706642,0.003894338,0.00089857954,0.004069755,0.0037396317],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002266058,0.00012232526,0.0010491681,0.006647849,0.0002013906,0.00037593048,0.00019805327,0.0013334631,0.06679198,0.042212076,0.090041354,0.7907998],"study_design_scores_gemma":[0.000025973388,0.00015301818,0.0011749258,0.00035228903,0.00006738546,0.0010505313,0.0001161824,0.0009904034,0.010778697,0.017994305,0.9672427,0.00005345983],"about_ca_topic_score_codex":0.001212526,"about_ca_topic_score_gemma":0.0016649257,"teacher_disagreement_score":0.004724668,"about_ca_system_score_codex":0.0019220015,"about_ca_system_score_gemma":0.0010043196,"threshold_uncertainty_score":0.01782155},"labels":[],"label_agreement":null},{"id":"W2166922847","doi":"10.1517/14728222.12.10.1289","title":"Proprotein convertases as therapeutic targets","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Proprotein Convertases; Proteases; Furin; Proprotein convertase; Serine; Biology; Cancer research; Bioinformatics; Enzyme; Medicine; Pharmacology; Biochemistry; Lipoprotein; Cholesterol; LDL receptor","score_opus":0.026145055120697806,"score_gpt":0.28257703260044015,"score_spread":0.25643197747974233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166922847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009407405,0.97055244,0.005888935,0.0042543756,0.0008100043,0.00005381708,0.00008296745,0.00007256384,0.008877495],"genre_scores_gemma":[0.08679209,0.8938221,0.006256949,0.0025918346,0.0012478266,0.00011903093,0.00024051809,0.000020093154,0.008909568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988735,0.00002729892,0.000008607847,0.000017721173,0.000039883293,0.000019084437],"domain_scores_gemma":[0.99988306,0.00004464019,0.000024185767,0.00000461479,0.00002885174,0.000014588827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048330514,0.0005155703,0.0005109405,0.00035311782,0.00010811522,0.0006112853,0.00042457247,0.0008555586,0.0026039407],"category_scores_gemma":[0.00024205577,0.00008998095,0.00018370013,0.00028349686,0.00026443417,0.00050320267,0.00021513579,0.0011632001,0.0011487319],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013419223,0.00034994338,0.00056965946,0.006467869,0.00010709048,0.0020114358,0.000091410504,0.0015315737,0.20087512,0.025804969,0.023663647,0.73718554],"study_design_scores_gemma":[0.0007148069,0.0020945147,0.0016113409,0.0012532398,0.00031602182,0.007433362,0.00012032714,0.0020111732,0.12624523,0.01867873,0.83947355,0.000047682002],"about_ca_topic_score_codex":0.00012517627,"about_ca_topic_score_gemma":0.00018099841,"teacher_disagreement_score":0.0026039407,"about_ca_system_score_codex":0.00042220714,"about_ca_system_score_gemma":0.0002539009,"threshold_uncertainty_score":0.0087111},"labels":[],"label_agreement":null},{"id":"W2168448982","doi":"10.1517/14728222.6.2.185","title":"Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"G protein-coupled receptor; Receptor; Drug discovery; Biology; Rhodopsin-like receptors; Signal transduction; Neuroscience; Computational biology; Class C GPCR; Neurotransmitter receptor; Metabotropic receptor; Bioinformatics; Cell biology; Genetics; Glutamate receptor","score_opus":0.04743990798451598,"score_gpt":0.3136720887402553,"score_spread":0.26623218075573934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168448982","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038781462,0.9962437,0.00059357,0.0010260225,0.00046450028,0.0000064564792,0.000015991862,0.00001609253,0.00124594],"genre_scores_gemma":[0.0009786184,0.9961434,0.0006404286,0.0006036425,0.0003263964,0.000009352996,0.00003454856,0.0000023677505,0.0012613271],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981993,0.000035324843,0.00002038923,0.000034652505,0.00007004165,0.000019681534],"domain_scores_gemma":[0.99980587,0.00006246822,0.00002287189,0.000008305625,0.00007299801,0.000027609927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071902305,0.0008367375,0.0015702664,0.0012715613,0.00023044321,0.0007986759,0.0010677945,0.0015361264,0.002720724],"category_scores_gemma":[0.00047458932,0.00022436159,0.00032761242,0.0015314062,0.00055808725,0.0018107453,0.00040954075,0.0016323102,0.0033423305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013852447,0.000087856904,0.00015200897,0.008098441,0.00004831307,0.0007348735,0.00006663467,0.0005712497,0.010035415,0.00641614,0.03239668,0.9412539],"study_design_scores_gemma":[0.000052670097,0.00016273395,0.000714631,0.0010852175,0.000066439155,0.0027181043,0.00008283822,0.0001866749,0.0019813168,0.0036750373,0.98925275,0.000021622362],"about_ca_topic_score_codex":0.0005669994,"about_ca_topic_score_gemma":0.0012580658,"teacher_disagreement_score":0.002720724,"about_ca_system_score_codex":0.0008687505,"about_ca_system_score_gemma":0.0008582969,"threshold_uncertainty_score":0.009101689},"labels":[],"label_agreement":null},{"id":"W2169040543","doi":"10.1517/14728222.2014.887683","title":"Targeting cell surface trafficking of pain-facilitating receptors to treat chronic pain conditions","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"Canadian Institutes of Health Research","keywords":"Nociceptor; Chronic pain; Receptor; Neuroscience; Sensitization; Transient receptor potential channel; Medicine; Nociception; Dorsal root ganglion; Nerve injury; Spinal cord; Biology; Internal medicine","score_opus":0.04591767924314502,"score_gpt":0.3591585857157716,"score_spread":0.3132409064726266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169040543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010741672,0.96133775,0.005845997,0.008902973,0.0027148363,0.00016462576,0.00047355884,0.0001758407,0.009642758],"genre_scores_gemma":[0.08156577,0.8950827,0.0037100955,0.006571211,0.002336301,0.00023729667,0.00087040657,0.000034880468,0.009591352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997397,0.00004876618,0.000017028433,0.000047906855,0.0000856876,0.00006085544],"domain_scores_gemma":[0.99985313,0.000029024572,0.000033646913,0.0000050362687,0.000060467257,0.000018786268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044094346,0.00044378013,0.0006280644,0.00038929182,0.00015338839,0.00066450844,0.00050182274,0.0010342874,0.0063180784],"category_scores_gemma":[0.00043283094,0.00010161908,0.00052502955,0.00022305369,0.0002818838,0.000636398,0.00040594416,0.0015114414,0.0022798674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009434407,0.00024757345,0.0008049876,0.027744383,0.00029429977,0.000742805,0.00023838828,0.0011646383,0.1581608,0.011773996,0.09365853,0.70422614],"study_design_scores_gemma":[0.00034259615,0.0013278512,0.0022691058,0.0033610626,0.0003832276,0.002311921,0.00018127442,0.0010958457,0.029839097,0.00471347,0.95411295,0.00006153509],"about_ca_topic_score_codex":0.00040345077,"about_ca_topic_score_gemma":0.0008629453,"teacher_disagreement_score":0.0063180784,"about_ca_system_score_codex":0.00043773712,"about_ca_system_score_gemma":0.00044786496,"threshold_uncertainty_score":0.021136105},"labels":[],"label_agreement":null},{"id":"W2169050233","doi":"10.1517/14728222.11.12.1523","title":"Targeting platelets for prevention and treatment of cardiovascular disease","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Pomegranate: compositions and health benefits","field":"Nursing","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"Florida State University","keywords":"Platelet; Medicine; Disease; Thrombosis; Nutraceutical; Platelet activation; Stroke (engine); Platelet aggregation; Bioinformatics; Internal medicine; Pathology; Biology","score_opus":0.1308887943018832,"score_gpt":0.41184152655984146,"score_spread":0.28095273225795825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169050233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022170656,0.9974362,0.00019232335,0.0004990111,0.00028774646,0.000011408552,0.000012947263,0.00000905865,0.0013296452],"genre_scores_gemma":[0.00097496953,0.99726176,0.0004272192,0.0002991555,0.00024300421,0.00001235257,0.000023486818,0.0000014026205,0.00075670215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997631,0.000044003016,0.000027392536,0.000032319724,0.00010981346,0.00002348475],"domain_scores_gemma":[0.99981254,0.000072290946,0.000033824166,0.000006578748,0.00005493734,0.000019809286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008151054,0.0009119171,0.0013453132,0.0020430933,0.00031632712,0.00066323415,0.0008274805,0.0016771156,0.004969766],"category_scores_gemma":[0.00055813853,0.00022570475,0.0006215634,0.0014537887,0.00041304476,0.0008768745,0.0005579471,0.0019665922,0.0032819659],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014004445,0.00023077031,0.00015087509,0.010650582,0.00010123711,0.00038314785,0.000060326354,0.00024252631,0.004267145,0.0024727802,0.02445881,0.95684177],"study_design_scores_gemma":[0.00017771323,0.0004039609,0.0015874521,0.0050275093,0.0002013359,0.0029398918,0.00009154062,0.00018338732,0.002121381,0.00279022,0.9844499,0.00002574024],"about_ca_topic_score_codex":0.0009360866,"about_ca_topic_score_gemma":0.0017073398,"teacher_disagreement_score":0.004969766,"about_ca_system_score_codex":0.0004890528,"about_ca_system_score_gemma":0.00084679364,"threshold_uncertainty_score":0.016625583},"labels":[],"label_agreement":null},{"id":"W2170877463","doi":"10.1517/14728222.2014.936382","title":"Consideration of GREB1 as a potential therapeutic target for hormone-responsive or endocrine-resistant cancers","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Prostate cancer; Estrogen; Breast cancer; Hormone; Cancer research; Cancer; Medicine; Bioinformatics; Biology; Internal medicine","score_opus":0.0314190946749713,"score_gpt":0.35908308866243205,"score_spread":0.32766399398746077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170877463","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016775676,0.99487454,0.00030120922,0.0017451624,0.0007964655,0.000010308573,0.000043260956,0.000015854917,0.002045359],"genre_scores_gemma":[0.0011106904,0.99560475,0.00032791644,0.0010952533,0.00040371274,0.000015675378,0.00006446185,0.0000029749206,0.0013746249],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984646,0.00003351711,0.000014642542,0.000024852327,0.00006207659,0.000018367244],"domain_scores_gemma":[0.9997929,0.00008597194,0.000028877132,0.00000517499,0.00006652032,0.000020611238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005236756,0.0005251867,0.000937797,0.0010472923,0.00018809526,0.00062442146,0.00087651814,0.0013352095,0.005001995],"category_scores_gemma":[0.0005695327,0.00016928255,0.0004517436,0.0008249631,0.00034155967,0.000944485,0.00041909041,0.0020234867,0.0026408564],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108604625,0.000058009588,0.0001066093,0.012704011,0.00009069464,0.00030133018,0.000047179456,0.0005089486,0.004244149,0.005816706,0.08286239,0.89315134],"study_design_scores_gemma":[0.00002902892,0.000077542645,0.00028618542,0.0017147838,0.00006268651,0.0007950103,0.000030657346,0.00010240228,0.0005114429,0.0018609038,0.9945182,0.000011061977],"about_ca_topic_score_codex":0.0005690584,"about_ca_topic_score_gemma":0.0014304515,"teacher_disagreement_score":0.005001995,"about_ca_system_score_codex":0.0006173977,"about_ca_system_score_gemma":0.00070812093,"threshold_uncertainty_score":0.016733348},"labels":[],"label_agreement":null},{"id":"W2170918501","doi":"10.1517/14728222.8.5.473","title":"Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Matrix metalloproteinase; Gene expression; Inflammation; Biology; Cancer; Bioinformatics; Computational biology; Signal transduction; Regulation of gene expression; Cancer research; Gene; Cell biology; Immunology; Genetics","score_opus":0.036853470002914036,"score_gpt":0.3278280470816489,"score_spread":0.29097457707873486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170918501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003548657,0.9932862,0.0009638186,0.0014786818,0.00066984276,0.000017728855,0.000026597774,0.000026790742,0.0031754521],"genre_scores_gemma":[0.0016726264,0.9931324,0.0013429372,0.0006773727,0.0004612459,0.000021795757,0.000053193628,0.0000039779115,0.0026344287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998037,0.00003766286,0.000017927627,0.00003344505,0.00008262578,0.000024747864],"domain_scores_gemma":[0.9997919,0.00007062908,0.000029943192,0.0000097386865,0.00006530921,0.000032487347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079202757,0.00093980733,0.0012074014,0.0015980167,0.00030606036,0.00083243597,0.0010483719,0.002048438,0.008416503],"category_scores_gemma":[0.00043892564,0.0002645691,0.00058541074,0.0011349282,0.0005712425,0.0015133892,0.00045629,0.0021799628,0.007341784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021672466,0.00020072659,0.00016128235,0.009303801,0.00009085674,0.0008524215,0.00007187948,0.00067593955,0.017496174,0.00857025,0.0519093,0.91045064],"study_design_scores_gemma":[0.00007353528,0.00018969568,0.0006462869,0.0013351461,0.000065828724,0.0021228592,0.000053709336,0.00014171959,0.0020616725,0.0029721854,0.9903177,0.00001974532],"about_ca_topic_score_codex":0.0006529519,"about_ca_topic_score_gemma":0.0016784176,"teacher_disagreement_score":0.008416503,"about_ca_system_score_codex":0.0008140838,"about_ca_system_score_gemma":0.0010740735,"threshold_uncertainty_score":0.028155982},"labels":[],"label_agreement":null},{"id":"W2293112675","doi":"10.1517/14728222.2016.1146695","title":"On the horizon: trophic peptide growth factors as therapy for neonatal short bowel syndrome","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Clinical Nutrition and Gastroenterology","field":"Nursing","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Short bowel syndrome; Glucagon-like peptide-2; Medicine; Population; Epidermal growth factor; Peptide; Bioinformatics; Internal medicine; Biology; Parenteral nutrition; Receptor; Biochemistry","score_opus":0.07984371693068733,"score_gpt":0.37621662614007323,"score_spread":0.2963729092093859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293112675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008894314,0.9977514,0.000075827345,0.00095963187,0.0005356765,0.0000041508906,0.000013356474,0.0000051323864,0.00056587945],"genre_scores_gemma":[0.00052562734,0.99793077,0.00013577679,0.00056643144,0.00038892694,0.0000064615565,0.000022563545,0.0000015721075,0.00042190673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998084,0.000045752033,0.000027325754,0.000026053114,0.00007558516,0.000017006458],"domain_scores_gemma":[0.9996388,0.00017672061,0.000053734355,0.000007581094,0.00009540119,0.000027708285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058031816,0.0005676803,0.0009101249,0.0009735253,0.0001861086,0.0006899955,0.00059569714,0.0011563054,0.0038915423],"category_scores_gemma":[0.0009613869,0.00012544154,0.0005218591,0.0008735317,0.00032494942,0.001133502,0.00048594052,0.0022757428,0.0018062898],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011380056,0.000051469357,0.00009221002,0.012527373,0.0000837263,0.00015067932,0.000047646157,0.00018767909,0.001033288,0.0025935147,0.045083057,0.93803555],"study_design_scores_gemma":[0.000052701213,0.00016850096,0.000766796,0.008950631,0.00014596818,0.0013237565,0.00009061063,0.00010699659,0.00044918442,0.0026956503,0.9852291,0.000020110736],"about_ca_topic_score_codex":0.000627067,"about_ca_topic_score_gemma":0.001327543,"teacher_disagreement_score":0.0038915423,"about_ca_system_score_codex":0.00039853307,"about_ca_system_score_gemma":0.00069153623,"threshold_uncertainty_score":0.013018429},"labels":[],"label_agreement":null},{"id":"W2308800788","doi":"10.1517/14728222.2016.1164695","title":"Calreticulin, a therapeutic target?","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Calreticulin; Immunogenic cell death; Unfolded protein response; Endoplasmic reticulum; Cell biology; Biology; Programmed cell death; Extracellular; Cell; Intracellular; Apoptosis; Biochemistry","score_opus":0.03550761811961399,"score_gpt":0.3494242121773451,"score_spread":0.3139165940577311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308800788","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015012515,0.9432276,0.0014801384,0.033415686,0.009166453,0.00004958812,0.0003618197,0.00011584172,0.010681625],"genre_scores_gemma":[0.015539214,0.92617,0.0016361766,0.027666375,0.009477482,0.000090222245,0.00073381583,0.000030449122,0.018656222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999814,0.000035666395,0.000011265929,0.000038267885,0.000069157984,0.000031649703],"domain_scores_gemma":[0.9998252,0.00004070596,0.000031174706,0.00000473616,0.00006921782,0.000028883906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039750742,0.00040542748,0.0006661917,0.0003491111,0.00016304238,0.00082345324,0.0005275558,0.0019811457,0.01051337],"category_scores_gemma":[0.00053505786,0.000084252904,0.00033855313,0.00029763053,0.00037925006,0.0009406184,0.0004611155,0.001950655,0.0048482404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003349776,0.00006720746,0.00018387564,0.009593398,0.000089123,0.0005021435,0.00006117681,0.00035149232,0.0108451005,0.008532362,0.2986488,0.67079026],"study_design_scores_gemma":[0.0000658478,0.00014539492,0.00029967036,0.0015020008,0.000047976115,0.0008724623,0.00004813519,0.00016072845,0.0015578588,0.003893006,0.991394,0.000012841456],"about_ca_topic_score_codex":0.0003614994,"about_ca_topic_score_gemma":0.0009587279,"teacher_disagreement_score":0.01051337,"about_ca_system_score_codex":0.0006221843,"about_ca_system_score_gemma":0.0005120021,"threshold_uncertainty_score":0.035170734},"labels":[],"label_agreement":null},{"id":"W2769549375","doi":"10.1080/14728222.2018.1406924","title":"Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Hungarian Scientific Research Fund; Canadian Institutes of Health Research; Austrian Science Fund; Österreichische Forschungsförderungsgesellschaft; Canada Research Chairs","keywords":"Biology; Cancer research; Epigenetics; Leukemia; Haematopoiesis; Chromatin remodeling; Myeloproliferative Disorders; JAK-STAT signaling pathway; Cancer; Lymphoma; Carcinogenesis; Signal transduction; Genetics; Immunology; Gene; Stem cell; Receptor tyrosine kinase","score_opus":0.07735420331731752,"score_gpt":0.39340608895262985,"score_spread":0.31605188563531234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769549375","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000174938,0.9968316,0.00018145143,0.0011020824,0.0004185569,0.000007231387,0.00003957479,0.000012659917,0.0012319118],"genre_scores_gemma":[0.0012491655,0.9963588,0.00026546742,0.00086229836,0.00036794986,0.000011682226,0.00007684686,0.000002557976,0.0008052588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998247,0.00003512205,0.000021716087,0.000029342944,0.00006586811,0.000023273757],"domain_scores_gemma":[0.99974376,0.00010855902,0.00004270269,0.0000053493764,0.00007622298,0.000023388324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048884045,0.0005265474,0.0009900461,0.0011695342,0.00018382611,0.00068063545,0.0007420559,0.0011443562,0.0051942077],"category_scores_gemma":[0.0006187208,0.0001416301,0.0005792856,0.0007806936,0.00028728376,0.0008794528,0.00051619724,0.0019512567,0.0022368205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009295855,0.000057281137,0.00011749819,0.012479963,0.000095583215,0.00021296594,0.000041693107,0.00041948102,0.0021861289,0.004301694,0.050247632,0.9297471],"study_design_scores_gemma":[0.000036713725,0.00011405462,0.00037684647,0.003569507,0.000111499176,0.0010380093,0.000043264623,0.0001383379,0.0005072467,0.0025051013,0.9915469,0.000012492216],"about_ca_topic_score_codex":0.00046903998,"about_ca_topic_score_gemma":0.0013361584,"teacher_disagreement_score":0.0051942077,"about_ca_system_score_codex":0.0005012655,"about_ca_system_score_gemma":0.0005622405,"threshold_uncertainty_score":0.017376363},"labels":[],"label_agreement":null},{"id":"W2897137871","doi":"10.1080/14728222.2018.1535595","title":"EGFL7 – a potential therapeutic target for multiple sclerosis?","year":2018,"lang":"en","type":"editorial","venue":"Expert Opinion on Therapeutic Targets","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Deutsche Forschungsgemeinschaft","keywords":"Multiple sclerosis; Medicine; Neuroscience; Pharmacology; Intensive care medicine; Immunology; Biology","score_opus":0.05885040147917182,"score_gpt":0.335107386461153,"score_spread":0.2762569849819812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897137871","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016220142,0.095210396,0.0003360052,0.091219515,0.81019366,0.0000322313,0.00012379921,0.00007294283,0.0026492043],"genre_scores_gemma":[0.001466301,0.07008788,0.00035999643,0.058192827,0.8568351,0.000052480023,0.00010710856,0.00003214946,0.012866168],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983901,0.00035583533,0.0002494239,0.00017300715,0.0006592887,0.00017243953],"domain_scores_gemma":[0.99617404,0.001498993,0.00041180424,0.00009623083,0.0012761644,0.0005428496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034360525,0.0015832537,0.0023789655,0.0014560216,0.0010489393,0.0030120183,0.0021751316,0.011913041,0.009230147],"category_scores_gemma":[0.007858264,0.0005367973,0.001480169,0.0006363219,0.0014027648,0.0030709433,0.0011878307,0.010929671,0.006563618],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012372239,0.000020200594,0.000034273904,0.0008073321,0.00004485713,0.00024071909,0.000012510806,0.000036146812,0.00026316143,0.000616257,0.96783644,0.029964454],"study_design_scores_gemma":[0.00013725008,0.0000693964,0.00012774012,0.0005480054,0.000091731934,0.0004180946,0.000022025784,0.00010024533,0.00023237802,0.0012091025,0.9970276,0.000016467253],"about_ca_topic_score_codex":0.0006353214,"about_ca_topic_score_gemma":0.0016797483,"teacher_disagreement_score":0.011913041,"about_ca_system_score_codex":0.0015271425,"about_ca_system_score_gemma":0.0019538,"threshold_uncertainty_score":0.030877888},"labels":[],"label_agreement":null},{"id":"W2911536945","doi":"10.1080/14728222.2019.1581764","title":"Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Agmatine; Polyamine; Neuroprotection; Antidepressant; Bipolar disorder; Depression (economics); Neuroscience; Medicine; Pathophysiology; Inflammation; Pharmacology; Bioinformatics; Biology; Internal medicine; Hippocampus; Biochemistry","score_opus":0.07289562796849804,"score_gpt":0.40789693711439856,"score_spread":0.33500130914590054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911536945","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019457274,0.99763584,0.000099279234,0.00074274285,0.0002464173,0.0000071186346,0.000029453178,0.000005998849,0.0010385812],"genre_scores_gemma":[0.001533451,0.9969279,0.00016651573,0.0005355193,0.00025190675,0.000010746794,0.000040835595,0.0000014949467,0.0005316281],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989486,0.000028096745,0.000014880375,0.000020432184,0.000031574324,0.000010109533],"domain_scores_gemma":[0.9997272,0.000142011,0.000042620653,0.0000055170453,0.00006392897,0.000018682656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044393388,0.00043290088,0.00077053474,0.00066597713,0.00016344928,0.0007042875,0.00052422844,0.0010058619,0.004911932],"category_scores_gemma":[0.0006265736,0.0001353875,0.00048245818,0.000559359,0.0002584668,0.00061103946,0.0003359032,0.0013627231,0.0015983749],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017231499,0.000054023476,0.0001282964,0.022180308,0.000113508206,0.00017591663,0.000050381932,0.0002160428,0.002319641,0.002971368,0.022158964,0.9494592],"study_design_scores_gemma":[0.000108173546,0.0004614016,0.0014260925,0.014973726,0.00037587638,0.0014495299,0.00009027539,0.00023601062,0.0009379902,0.0040148306,0.9758986,0.000027426382],"about_ca_topic_score_codex":0.00070589513,"about_ca_topic_score_gemma":0.0022093083,"teacher_disagreement_score":0.004911932,"about_ca_system_score_codex":0.00035649503,"about_ca_system_score_gemma":0.00065419823,"threshold_uncertainty_score":0.016432047},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2938535502","doi":"10.1080/14728222.2019.1606904","title":"The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer","year":2019,"lang":"en","type":"editorial","venue":"Expert Opinion on Therapeutic Targets","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Dopamine receptor D2; Pancreatic ductal adenocarcinoma; Pancreatic cancer; Cancer; Dopamine; Adenocarcinoma; Medicine; Cancer research; Receptor; Dopamine receptor; Internal medicine; Oncology; Neuroscience; Biology","score_opus":0.02769456255212246,"score_gpt":0.37656284114343563,"score_spread":0.3488682785913132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938535502","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015940778,0.041071516,0.00027432438,0.052617393,0.9026801,0.000043218468,0.00013274926,0.000067206725,0.0029540788],"genre_scores_gemma":[0.0013236969,0.038547568,0.00024232172,0.048206903,0.8956771,0.000044857174,0.00008551402,0.000032432028,0.015839633],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998278,0.00030141385,0.00022869556,0.00021149388,0.0008158876,0.00016447363],"domain_scores_gemma":[0.99592495,0.0016868043,0.0003749262,0.00010761256,0.0013219615,0.0005837568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035245437,0.0019462373,0.0019414814,0.001549745,0.0012168776,0.003348671,0.0021841584,0.010030493,0.008353333],"category_scores_gemma":[0.0076027783,0.000665499,0.001987552,0.0007690086,0.0013328285,0.002419469,0.0009890542,0.012303104,0.0054836962],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011380608,0.000020197962,0.00003076783,0.00059279235,0.000045059216,0.00015783602,0.000011475585,0.000040442163,0.00021376161,0.0005670464,0.97833806,0.019868841],"study_design_scores_gemma":[0.00019542332,0.000090247035,0.00019265097,0.00043889665,0.000119593016,0.00035540998,0.000021404418,0.00013408223,0.00032840457,0.0012704268,0.99683493,0.000018555293],"about_ca_topic_score_codex":0.0011259109,"about_ca_topic_score_gemma":0.0031718775,"teacher_disagreement_score":0.010030493,"about_ca_system_score_codex":0.0021487488,"about_ca_system_score_gemma":0.0023799017,"threshold_uncertainty_score":0.027944624},"labels":[],"label_agreement":null},{"id":"W2951436114","doi":"10.1080/14728222.2019.1628948","title":"Cystic Fibrosis: Proteostatic correctors of CFTR trafficking and alternative therapeutic targets.","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Proteostasis; Cystic fibrosis; Endoplasmic reticulum; Cystic fibrosis transmembrane conductance regulator; Cell biology; Synthetic lethality; Biology; Endoplasmic-reticulum-associated protein degradation; Mutation; Mutant; Unfolded protein response; Bioinformatics; Cancer research; Genetics; Gene","score_opus":0.07349842931428337,"score_gpt":0.39663231449997216,"score_spread":0.3231338851856888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951436114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015939465,0.9950978,0.00021346456,0.001067791,0.0008324333,0.000011980644,0.00006259265,0.000021040787,0.0025334333],"genre_scores_gemma":[0.0011867052,0.99383944,0.00031498866,0.0009866954,0.00057637057,0.000015467896,0.00012862535,0.0000045803313,0.0029471095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983776,0.00002562335,0.000013429639,0.000025621543,0.00007428291,0.0000233046],"domain_scores_gemma":[0.99985397,0.000043854765,0.000024989646,0.0000048495995,0.00004964981,0.00002261531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038186373,0.0006521092,0.0009200642,0.0012126894,0.00021241858,0.00082242244,0.00059975905,0.0011173859,0.007641342],"category_scores_gemma":[0.00041241464,0.00016931708,0.00045060844,0.0008959805,0.0003120328,0.001022059,0.0005728072,0.001983235,0.004517984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009463866,0.000061536055,0.00007713803,0.013300019,0.00006524543,0.00022319247,0.000054571505,0.000258605,0.00450394,0.0053061694,0.095960505,0.88009435],"study_design_scores_gemma":[0.000017072558,0.00006984392,0.00026748108,0.002036712,0.000037441274,0.0006418619,0.000025778598,0.000054415148,0.00035749053,0.0015417339,0.994941,0.0000092840755],"about_ca_topic_score_codex":0.0006505524,"about_ca_topic_score_gemma":0.0017560215,"teacher_disagreement_score":0.007641342,"about_ca_system_score_codex":0.00055557047,"about_ca_system_score_gemma":0.00065864786,"threshold_uncertainty_score":0.025562823},"labels":[],"label_agreement":null},{"id":"W3035846272","doi":"10.1080/14728222.2020.1783242","title":"Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Thymic stromal lymphopoietin; Asthma; Medicine; Immunology; Pharmacology","score_opus":0.02858444432175242,"score_gpt":0.3366293091842782,"score_spread":0.30804486486252575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035846272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000975825,0.99879956,0.00004454298,0.0003534895,0.00021067452,0.0000028328948,0.000009376085,0.0000031230093,0.00047875982],"genre_scores_gemma":[0.0010321442,0.9975853,0.00013179959,0.00036905546,0.0003564227,0.000007111162,0.000021826312,0.0000010883919,0.00049515546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998547,0.000033243996,0.000015889425,0.000020806794,0.000057115343,0.000018300343],"domain_scores_gemma":[0.99979645,0.00009273202,0.00003920519,0.000004200257,0.000048169706,0.000019277008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004171175,0.00052277267,0.0011608204,0.0011237952,0.00016866883,0.00081183034,0.0006198883,0.0012998645,0.0048300107],"category_scores_gemma":[0.00049911457,0.00015445848,0.00044011767,0.0011739128,0.00030511495,0.0008975164,0.00041075866,0.0014670269,0.0022714487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017505122,0.00008837581,0.00012591979,0.02094126,0.000095045885,0.00043429257,0.000052932795,0.00032302583,0.003008343,0.0021550485,0.04090919,0.93169165],"study_design_scores_gemma":[0.00012464511,0.00024235598,0.0011426363,0.0076678926,0.0001833136,0.002802177,0.000091360744,0.00018679211,0.0007191653,0.0020538387,0.9847621,0.00002388186],"about_ca_topic_score_codex":0.0005124393,"about_ca_topic_score_gemma":0.0010704701,"teacher_disagreement_score":0.0048300107,"about_ca_system_score_codex":0.0003867919,"about_ca_system_score_gemma":0.0006473153,"threshold_uncertainty_score":0.016157985},"labels":[],"label_agreement":null},{"id":"W3113060561","doi":"10.1080/14728222.2021.1861249","title":"HSP47: a potential target for fibrotic diseases and implications for therapy","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Agence Nationale de la Recherche","keywords":"Fibrosis; In vivo; Medicine; Biomarker; Pathology; Pulmonary fibrosis; Cancer research; Biology; Biochemistry","score_opus":0.07200161049709645,"score_gpt":0.40326501107846185,"score_spread":0.3312634005813654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113060561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014416529,0.99759406,0.000108170636,0.0007573323,0.00033211548,0.000003937463,0.000017802216,0.0000072878447,0.0010351273],"genre_scores_gemma":[0.0010677124,0.9970829,0.00015730324,0.00040700976,0.00030968987,0.000009371492,0.000036488207,0.0000017988201,0.00092778524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987257,0.000033543376,0.000013590231,0.00001920434,0.00004490509,0.000016175594],"domain_scores_gemma":[0.99982846,0.00006805997,0.000027750066,0.00000592014,0.00005039467,0.00001930699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039107725,0.0005869556,0.001098198,0.001041573,0.00020993454,0.0006982753,0.00046430487,0.0011706037,0.005820357],"category_scores_gemma":[0.00039941655,0.00014766854,0.0004064547,0.0011677231,0.00038084708,0.00097412645,0.0004061348,0.0012078194,0.0036785074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000163918,0.00008437398,0.00020602439,0.01949035,0.0000820986,0.00045700357,0.000067879795,0.0003315477,0.0055444473,0.0054324996,0.07037296,0.8977669],"study_design_scores_gemma":[0.00004093782,0.00017020863,0.0010593504,0.004331288,0.00008785494,0.0020579146,0.0000852992,0.00012148253,0.001173427,0.0031482026,0.98770547,0.000018663255],"about_ca_topic_score_codex":0.00039003958,"about_ca_topic_score_gemma":0.0006596077,"teacher_disagreement_score":0.005820357,"about_ca_system_score_codex":0.000445249,"about_ca_system_score_gemma":0.00075665093,"threshold_uncertainty_score":0.01947105},"labels":[],"label_agreement":null},{"id":"W3150731771","doi":"10.1080/14728222.2021.1915993","title":"Targeting neuroprotective functions of astrocytes in neuroimmune diseases","year":2021,"lang":"en","type":"editorial","venue":"Expert Opinion on Therapeutic Targets","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Neuroprotection; Neuroscience; Central nervous system; Astrocyte; Homeostasis; Neuroinflammation; Biology; Nervous system; Medicine; Immunology; Inflammation; Cell biology","score_opus":0.028793374270692056,"score_gpt":0.29636115746779407,"score_spread":0.267567783197102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3150731771","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000094805306,0.05237557,0.00030533082,0.03755732,0.90730333,0.00003168066,0.00006116318,0.00006404762,0.00220678],"genre_scores_gemma":[0.0008579112,0.051187467,0.00022548028,0.0322986,0.9041237,0.00003174045,0.000055894066,0.000035241996,0.011183964],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982023,0.0003256328,0.00025005118,0.0001984068,0.0008847364,0.00013882606],"domain_scores_gemma":[0.9951201,0.0020262036,0.0002579663,0.00010647689,0.0018268728,0.0006623534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048876316,0.0026239667,0.0022947427,0.0013716148,0.0015105257,0.0034274028,0.0026282007,0.009489957,0.0058312383],"category_scores_gemma":[0.007787891,0.00069133396,0.0016058038,0.0006784148,0.0017733866,0.0034305037,0.001399839,0.016883194,0.0054807146],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009019128,0.000018656805,0.000016857864,0.0005661679,0.00002923127,0.00016427317,0.00002233875,0.000046057507,0.0002482164,0.00083082874,0.9785608,0.019406334],"study_design_scores_gemma":[0.000083726954,0.00006076517,0.00014336096,0.0005731543,0.000062479674,0.00034657953,0.000027235254,0.00012329823,0.00024624614,0.0016714919,0.9966454,0.000016256756],"about_ca_topic_score_codex":0.0010664709,"about_ca_topic_score_gemma":0.0034615658,"teacher_disagreement_score":0.009489957,"about_ca_system_score_codex":0.0019914545,"about_ca_system_score_gemma":0.0018269158,"threshold_uncertainty_score":0.025848567},"labels":[],"label_agreement":null},{"id":"W3202456313","doi":"10.1080/14728222.2021.1989410","title":"Transglutaminase 2 as a therapeutic target for neurological conditions","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Blood properties and coagulation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Tissue transglutaminase; Context (archaeology); Multiple sclerosis; Disease; Mechanism (biology); Medicine; Neurodegeneration; Amyotrophic lateral sclerosis; Neuroscience; Bioinformatics; Biology; Pathology; Immunology; Enzyme; Biochemistry","score_opus":0.11639714725605277,"score_gpt":0.4058020030625831,"score_spread":0.28940485580653036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202456313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012430159,0.9964026,0.00012349998,0.00067782926,0.00053214486,0.000009724147,0.000051710624,0.000013759581,0.0020644362],"genre_scores_gemma":[0.0011433406,0.99563885,0.00022060642,0.00074423506,0.00040411623,0.000015336502,0.000111197005,0.0000038328462,0.0017184843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998547,0.000030617597,0.00001724406,0.000024930083,0.000056110504,0.000016340242],"domain_scores_gemma":[0.9998361,0.000067730005,0.000027324659,0.000004131384,0.00004936724,0.000015366328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034237062,0.00056564785,0.0009464226,0.0013558528,0.00015464817,0.0007150787,0.00055883854,0.0010942849,0.008044077],"category_scores_gemma":[0.00053858844,0.00013128619,0.00053898775,0.0011016525,0.00021345727,0.0007572262,0.00043923478,0.0016767954,0.0037829229],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001332289,0.00006165176,0.00008218443,0.025873259,0.00012270319,0.00024827322,0.000049873433,0.00024689507,0.002875152,0.003880726,0.108301945,0.85812414],"study_design_scores_gemma":[0.00003579941,0.000097435,0.00034066214,0.0047450764,0.00012254594,0.00083637045,0.000023462004,0.00007867676,0.00050941156,0.0013622977,0.99183697,0.000011330065],"about_ca_topic_score_codex":0.00068514165,"about_ca_topic_score_gemma":0.0015650525,"teacher_disagreement_score":0.008044077,"about_ca_system_score_codex":0.00048647536,"about_ca_system_score_gemma":0.00061573385,"threshold_uncertainty_score":0.026910067},"labels":[],"label_agreement":null},{"id":"W3212524944","doi":"10.1080/14728222.2021.2006186","title":"Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Disease; Clinical trial; Drug development; Therapeutic approach; Drug; Precision medicine; Bioinformatics; Intensive care medicine; Lung; Pharmacology; Internal medicine; Pathology; Biology","score_opus":0.07511358586126267,"score_gpt":0.40445285585001606,"score_spread":0.3293392699887534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212524944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017257543,0.9969982,0.00023086979,0.0008880449,0.0003766699,0.000011008164,0.000044956778,0.000010101109,0.0012675619],"genre_scores_gemma":[0.0012682416,0.9967269,0.0002868155,0.000587302,0.00029231908,0.0000149295065,0.000081057646,0.0000026537784,0.0007398209],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997266,0.00006169341,0.000027873295,0.00004127869,0.00010603839,0.00003650678],"domain_scores_gemma":[0.9994498,0.0002462878,0.00007390558,0.0000133229705,0.0001703955,0.00004637644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009661231,0.0006214349,0.0011324163,0.0013378105,0.00021631521,0.0012908649,0.00078934646,0.001371486,0.006269418],"category_scores_gemma":[0.0011052486,0.0001911167,0.0006975061,0.0009580814,0.0004144836,0.0012089182,0.0006454539,0.002223606,0.0029452732],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001603755,0.0000850235,0.00015040717,0.021529162,0.00010367089,0.0002547315,0.000078329555,0.0004654338,0.004302339,0.006156742,0.04043614,0.9262776],"study_design_scores_gemma":[0.00004406903,0.00023878174,0.00060361414,0.0069468413,0.00014358344,0.0009701551,0.00007072855,0.00018017455,0.0009703549,0.0032203428,0.98659,0.000021458285],"about_ca_topic_score_codex":0.00053754094,"about_ca_topic_score_gemma":0.0012182803,"teacher_disagreement_score":0.006269418,"about_ca_system_score_codex":0.00050312956,"about_ca_system_score_gemma":0.0010225435,"threshold_uncertainty_score":0.020973325},"labels":[],"label_agreement":null},{"id":"W3212864445","doi":"10.1080/14728222.2021.2008907","title":"<i>Clostridioides difficile</i>: innovations in target discovery and potential for therapeutic success","year":2021,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Medical Research Council; National Institute for Health and Care Research","keywords":"Clostridioides; Medicine; Drug discovery; Clinical trial; Drug; Intensive care medicine; Bioinformatics; Biology; Pharmacology","score_opus":0.035262177614949104,"score_gpt":0.3356124338975195,"score_spread":0.3003502562825704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212864445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008785925,0.97695494,0.0011174008,0.014050718,0.0018319318,0.000018716843,0.000110637615,0.00005248197,0.0049845413],"genre_scores_gemma":[0.011273016,0.97466654,0.002569255,0.0062801824,0.0026273702,0.000038047678,0.00017270187,0.000021124439,0.002351833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899715,0.00030084554,0.00010711767,0.00013548936,0.00032590516,0.00013351772],"domain_scores_gemma":[0.9974649,0.0013146203,0.0004494841,0.00007164626,0.0005289572,0.00017052382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023531534,0.00058367307,0.001222384,0.0012934776,0.00028512295,0.0023022527,0.00072989834,0.0020674358,0.006739434],"category_scores_gemma":[0.0031138284,0.0001642459,0.0007458061,0.0016750172,0.0009757841,0.0022095921,0.0007534088,0.0019221068,0.002302267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003333459,0.000066534776,0.00058709935,0.026255237,0.00016320722,0.00069268775,0.00015699229,0.00048517037,0.008663371,0.02040955,0.11801616,0.8241706],"study_design_scores_gemma":[0.00007517231,0.00038635265,0.0013593208,0.011101444,0.00019307107,0.0017321624,0.00024105454,0.00038267102,0.003126338,0.014803641,0.9665545,0.000044269047],"about_ca_topic_score_codex":0.0011816095,"about_ca_topic_score_gemma":0.0021851084,"teacher_disagreement_score":0.006739434,"about_ca_system_score_codex":0.0017224271,"about_ca_system_score_gemma":0.0024039529,"threshold_uncertainty_score":0.022545636},"labels":[],"label_agreement":null},{"id":"W4214592576","doi":"10.1080/14728222.2022.2047178","title":"Calpain as a therapeutic target in cancer","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Calpain Protease Function and Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Calpain; Cancer; Medicine; Cancer research; Biology; Computational biology; Pharmacology; Internal medicine; Biochemistry; Enzyme","score_opus":0.06370134639848704,"score_gpt":0.3783406912926034,"score_spread":0.3146393448941164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214592576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001300817,0.996736,0.0001852676,0.0007736494,0.00055325043,0.000006470571,0.000025778305,0.000013223954,0.0015763418],"genre_scores_gemma":[0.0013314368,0.99603647,0.00020566146,0.0006759154,0.0004100674,0.000009258044,0.0000578111,0.0000030427998,0.0012703271],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998524,0.000027649949,0.000012002913,0.000028504619,0.000059764516,0.000019611874],"domain_scores_gemma":[0.9998592,0.000059174414,0.000019649431,0.0000047451285,0.000040832118,0.000016290478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038252302,0.00060449215,0.0008710618,0.0010094345,0.00019925114,0.00077974267,0.0007049731,0.0012319771,0.0050772014],"category_scores_gemma":[0.0004737658,0.00014739326,0.00043815168,0.000746504,0.00037980938,0.0008377802,0.00055582204,0.0023923032,0.0024065238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012240723,0.00006258464,0.00007529641,0.01392982,0.000095041905,0.00025097514,0.000045818302,0.00046403354,0.0040741772,0.0075271763,0.075787604,0.89756507],"study_design_scores_gemma":[0.00003106065,0.0001072559,0.00028265468,0.0022699968,0.00005924561,0.0009423711,0.000021206746,0.00011356768,0.000654739,0.00295508,0.9925523,0.0000105059125],"about_ca_topic_score_codex":0.0005978599,"about_ca_topic_score_gemma":0.0011616145,"teacher_disagreement_score":0.0050772014,"about_ca_system_score_codex":0.00059131905,"about_ca_system_score_gemma":0.00059696374,"threshold_uncertainty_score":0.016985},"labels":[],"label_agreement":null},{"id":"W4306315302","doi":"10.1080/14728222.2022.2137020","title":"The molecular mechanisms and targeting strategies of transcription factors in cholangiocarcinoma","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Natural Science Foundation of Zhejiang Province; National Natural Science Foundation of China","keywords":"Transcription factor; Cancer research; Biology; Epigenetics; KRAS; Carcinogenesis; Intrahepatic Cholangiocarcinoma; Malignancy; Transcription (linguistics); Bioinformatics; Cancer; Medicine; Internal medicine; Genetics; Gene; Colorectal cancer","score_opus":0.06819705147010136,"score_gpt":0.34751116145624517,"score_spread":0.2793141099861438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306315302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011776965,0.99848074,0.00012547267,0.0004021805,0.0002088386,0.000003820131,0.000020746324,0.0000052870014,0.0006351497],"genre_scores_gemma":[0.00085163995,0.9982077,0.00012661052,0.00023376131,0.00013949556,0.0000063647344,0.000034214307,0.0000010331028,0.00039929955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986994,0.00002703772,0.000017485774,0.000024680772,0.00004349377,0.000017255807],"domain_scores_gemma":[0.99985003,0.00007338948,0.000021820731,0.000003973979,0.000040678176,0.000010156992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003705114,0.000558121,0.0008091785,0.0011042189,0.0001659367,0.0006080983,0.0005366407,0.00078325585,0.0030075382],"category_scores_gemma":[0.00051127176,0.00017078286,0.0005886806,0.00080230105,0.00030799373,0.00083068275,0.000373193,0.0014219913,0.0012438204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013032941,0.00005235305,0.00018530877,0.028587015,0.00013805708,0.0002589575,0.00008239277,0.00066204416,0.004805339,0.006434916,0.03961402,0.9190492],"study_design_scores_gemma":[0.000025712587,0.00013287034,0.00061207026,0.004207534,0.00013973044,0.00096765714,0.000049837494,0.00013841307,0.0010777174,0.0026049218,0.9900281,0.000015564388],"about_ca_topic_score_codex":0.00085300306,"about_ca_topic_score_gemma":0.0017310113,"teacher_disagreement_score":0.0030075382,"about_ca_system_score_codex":0.00049897423,"about_ca_system_score_gemma":0.00073603075,"threshold_uncertainty_score":0.010061204},"labels":[],"label_agreement":null},{"id":"W4313877335","doi":"10.1080/14728222.2022.2166830","title":"DDX3: a relevant therapeutic target for lymphoma?","year":2022,"lang":"en","type":"editorial","venue":"Expert Opinion on Therapeutic Targets","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Lymphoma; Cancer research; Medicine; Computational biology; Biology; Immunology","score_opus":0.015125440634053888,"score_gpt":0.3009397313811786,"score_spread":0.28581429074712467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313877335","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012484171,0.1096947,0.00043512334,0.09162388,0.7935938,0.000048208953,0.00016528448,0.00011330039,0.004200778],"genre_scores_gemma":[0.0014042249,0.07183533,0.0003895268,0.07971001,0.82996655,0.000071724375,0.00015243377,0.000056183246,0.016413946],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821496,0.00040975853,0.00019685325,0.00021605591,0.0007747567,0.0001876557],"domain_scores_gemma":[0.9963922,0.0013705769,0.00034809485,0.00010702026,0.0011206823,0.0006614202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041476497,0.0019957826,0.0025601194,0.0014464194,0.0011324617,0.0037773224,0.0025455928,0.012100124,0.009875868],"category_scores_gemma":[0.008118647,0.00072372035,0.0015913426,0.00082010945,0.0016395701,0.0030091,0.0013234729,0.013613546,0.007846028],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084245636,0.000012001619,0.000015798489,0.00048450622,0.00002876547,0.00011558648,0.0000069995413,0.00003229196,0.0001646082,0.0005769781,0.9813059,0.0171723],"study_design_scores_gemma":[0.00014294378,0.00005820526,0.00011674123,0.00039370605,0.00008253707,0.00028423755,0.000014754116,0.00010966372,0.00017976506,0.0017963491,0.9968053,0.000015868578],"about_ca_topic_score_codex":0.0009230289,"about_ca_topic_score_gemma":0.0022034822,"teacher_disagreement_score":0.012100124,"about_ca_system_score_codex":0.0022954403,"about_ca_system_score_gemma":0.0021048968,"threshold_uncertainty_score":0.03303808},"labels":[],"label_agreement":null},{"id":"W4315928178","doi":"10.1080/14728222.2022.2168188","title":"Targeting BMPR-II in pulmonary arterial hypertension: a case of Hercules versus the Hydra?","year":2022,"lang":"en","type":"editorial","venue":"Expert Opinion on Therapeutic Targets","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lernaean Hydra; Pulmonary hypertension; Medicine; Cardiology; Internal medicine; Biology; Cell biology","score_opus":0.045184825970907797,"score_gpt":0.3391770330565959,"score_spread":0.29399220708568813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315928178","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007867218,0.07663308,0.0007883482,0.17838761,0.7392102,0.000047635225,0.00008248482,0.000106715386,0.0039572893],"genre_scores_gemma":[0.0032977348,0.041114643,0.0004359763,0.09679772,0.850977,0.000033030916,0.00004452288,0.000033600772,0.0072656833],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990239,0.000218524,0.00016342376,0.00011414574,0.00038723316,0.00009270068],"domain_scores_gemma":[0.9971481,0.0020318967,0.00013980846,0.000052676656,0.00034608995,0.0002814432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025356866,0.0014579596,0.0019587567,0.0011547232,0.0010740423,0.0023388672,0.0024627422,0.01572974,0.0029664792],"category_scores_gemma":[0.008915276,0.0005610612,0.0015111809,0.00049879256,0.0017512703,0.0029763624,0.0010009583,0.015085842,0.0029179996],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013062345,0.000022085973,0.00010122757,0.00059109606,0.00005833636,0.004378268,0.00006172663,0.000056563866,0.00034026956,0.0017022445,0.9727278,0.01982977],"study_design_scores_gemma":[0.00020690897,0.00010128262,0.00035967169,0.0011271551,0.00015798344,0.012560738,0.00015347835,0.0004125121,0.00044642028,0.0036586025,0.9807695,0.000045766345],"about_ca_topic_score_codex":0.00087476434,"about_ca_topic_score_gemma":0.0022469277,"teacher_disagreement_score":0.01572974,"about_ca_system_score_codex":0.0013705597,"about_ca_system_score_gemma":0.00094356574,"threshold_uncertainty_score":0.013410151},"labels":[],"label_agreement":null},{"id":"W4322617172","doi":"10.1080/14728222.2023.2185133","title":"Emerging therapeutic targets for osteoarthritis","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Osteoarthritis; Medicine; Disease; Clinical trial; Bioinformatics; Pathology; Biology; Alternative medicine","score_opus":0.09265214984559993,"score_gpt":0.38927130186090697,"score_spread":0.29661915201530703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322617172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008539909,0.9974612,0.00013223325,0.0005297955,0.0004053243,0.000010800703,0.000033179724,0.0000087270955,0.0013332433],"genre_scores_gemma":[0.0008244075,0.99714667,0.00022274748,0.00061064854,0.00022207721,0.000013102799,0.000060324342,0.0000021156386,0.0008979335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965847,0.00006898705,0.00004582748,0.000050924988,0.00013938225,0.000036292753],"domain_scores_gemma":[0.99967754,0.00012706532,0.00006165745,0.000009325907,0.00010094434,0.000023485429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064794486,0.000790227,0.0012178505,0.0019045542,0.00021827348,0.0010406362,0.00071738614,0.0012544534,0.009275529],"category_scores_gemma":[0.0007671224,0.00018794664,0.00094040384,0.0012260157,0.0003660891,0.0010865694,0.0006269233,0.0020776263,0.003252601],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108878165,0.00006714823,0.0001029976,0.047346048,0.00020545928,0.00021214508,0.000069912996,0.0002603786,0.003406984,0.006359778,0.048044525,0.8938157],"study_design_scores_gemma":[0.000043116223,0.00011277973,0.00047807646,0.011020667,0.00021160202,0.0008123627,0.000054777323,0.00007766466,0.00050420687,0.0026704664,0.98399967,0.000014551191],"about_ca_topic_score_codex":0.00088882574,"about_ca_topic_score_gemma":0.0022135675,"teacher_disagreement_score":0.009275529,"about_ca_system_score_codex":0.000631513,"about_ca_system_score_gemma":0.0012190668,"threshold_uncertainty_score":0.031029701},"labels":[],"label_agreement":null},{"id":"W4328048316","doi":"10.1080/14728222.2023.2185511","title":"Parasite and host kinases as targets for antimalarials","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Malaria Research and Control","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Genentech; Ontario Genomics Institute; RMIT University; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; National Institutes of Health; Ontario Genomics; Genome Canada; McGill University; National Institute of Allergy and Infectious Diseases; Medical Research Council; Bayer; State Government of Victoria; Pfizer; Bristol-Myers Squibb","keywords":"Druggability; Kinase; Biology; Drug discovery; Kinome; Drug resistance; Plasmodium falciparum; Malaria; Computational biology; Bioinformatics; Cell biology; Immunology; Genetics; Gene","score_opus":0.12460516986616908,"score_gpt":0.44392775970695103,"score_spread":0.31932258984078193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328048316","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013283937,0.99666756,0.00019925677,0.00066270493,0.0004023559,0.00000769721,0.00003261708,0.0000093370845,0.0018856935],"genre_scores_gemma":[0.0014002963,0.9960361,0.00023226098,0.00042022113,0.00028847682,0.000010281705,0.000055813278,0.0000021030469,0.0015544314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981254,0.000034990575,0.000015585038,0.000031418396,0.00007852266,0.000026859587],"domain_scores_gemma":[0.99981505,0.00006723061,0.00003228847,0.000005111941,0.00006207666,0.000018228935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043895177,0.0007377519,0.0009380985,0.001327344,0.00018231444,0.000863665,0.00060339127,0.001013711,0.0065776617],"category_scores_gemma":[0.000454041,0.00021544268,0.000423623,0.001011526,0.00040792645,0.0010390141,0.0005580973,0.0018795774,0.0035159497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012474242,0.000056965353,0.00009256995,0.02020437,0.00008275441,0.00023558894,0.000059096918,0.00063712103,0.006151965,0.010513816,0.056846645,0.90499437],"study_design_scores_gemma":[0.00001778869,0.000090439455,0.00027299853,0.0022089593,0.000054961332,0.00044749153,0.000028263137,0.00012715714,0.00067375845,0.0025342419,0.9935334,0.000010529484],"about_ca_topic_score_codex":0.00097358506,"about_ca_topic_score_gemma":0.001878834,"teacher_disagreement_score":0.0065776617,"about_ca_system_score_codex":0.000707927,"about_ca_system_score_gemma":0.0007520621,"threshold_uncertainty_score":0.022004485},"labels":[],"label_agreement":null},{"id":"W4381164454","doi":"10.1080/14728222.2023.2199923","title":"Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute","keywords":"Pathogenesis; Disease; Biology; Medicine; Computational biology; Immunology; Neuroscience; Pathology","score_opus":0.020405905373508237,"score_gpt":0.3104624357681918,"score_spread":0.2900565303946836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381164454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006448171,0.98543674,0.0012945249,0.008228093,0.0014283296,0.000022790318,0.000059845377,0.000035284167,0.0028495835],"genre_scores_gemma":[0.007361681,0.98190594,0.001465094,0.0045628296,0.0022733368,0.000053571544,0.00014619055,0.000007814155,0.0022235494],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9997595,0.000072057024,0.000014364188,0.00003760205,0.00007918815,0.000037339432],"domain_scores_gemma":[0.99975735,0.00008215774,0.000034841934,0.000009212227,0.000082361235,0.00003418621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009062846,0.0005728318,0.00096689153,0.00055375317,0.00023841097,0.0011324763,0.00084802863,0.0020044786,0.0037001004],"category_scores_gemma":[0.00057224656,0.000140456,0.00041383415,0.00033126032,0.0006728576,0.0011358919,0.0005368543,0.0022628973,0.0021975802],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041656356,0.00020343432,0.00034902478,0.013766245,0.0001485289,0.0010764067,0.00015360628,0.0011381515,0.02235023,0.024426239,0.18154901,0.75442266],"study_design_scores_gemma":[0.00012863509,0.0004195297,0.00076772895,0.004925964,0.00014645029,0.002401755,0.00016252241,0.00058166217,0.002940153,0.01963068,0.96785754,0.000037356313],"about_ca_topic_score_codex":0.000523247,"about_ca_topic_score_gemma":0.0012530616,"teacher_disagreement_score":0.0037001004,"about_ca_system_score_codex":0.0006901448,"about_ca_system_score_gemma":0.0007732482,"threshold_uncertainty_score":0.012378097},"labels":[],"label_agreement":null},{"id":"W4382048782","doi":"10.1080/14728222.2023.2230364","title":"SCN1A as a therapeutic target for Dravet syndrome","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Dravet syndrome; Medicine; Epilepsy; Pediatrics; Encephalopathy; Epilepsy syndromes; Sodium channel blocker; Disease; Bioinformatics; Sodium channel; Psychiatry; Internal medicine; Biology","score_opus":0.15794953117738397,"score_gpt":0.45185998624971424,"score_spread":0.29391045507233027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382048782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001381192,0.99741566,0.00011363868,0.0005063077,0.0003903163,0.000009073428,0.000036431316,0.000008500464,0.0013818839],"genre_scores_gemma":[0.001152751,0.9970414,0.00018952228,0.00048888277,0.00019733397,0.000011569868,0.00006201512,0.0000022895986,0.00085429684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998524,0.000029871899,0.000019048039,0.000027782164,0.000054116874,0.000016739672],"domain_scores_gemma":[0.99980253,0.00009498792,0.00003299936,0.000004486417,0.000050472867,0.000014584286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003918701,0.00057766517,0.0009190693,0.0010477598,0.00014516631,0.0006713655,0.00065466604,0.0009940251,0.0071028015],"category_scores_gemma":[0.00064813567,0.00013173035,0.0006711787,0.0007455674,0.00023267196,0.00066954666,0.00042946034,0.0016042199,0.0021095814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001135224,0.000048162932,0.00008559695,0.025050715,0.00013791907,0.00015267094,0.000042888547,0.00036765073,0.0016296154,0.00381379,0.041179094,0.9273784],"study_design_scores_gemma":[0.00006865489,0.00016612733,0.0005411312,0.009756943,0.0002603661,0.0009756548,0.000045037774,0.00016394875,0.00048455162,0.0025136506,0.98500735,0.00001653261],"about_ca_topic_score_codex":0.00093871687,"about_ca_topic_score_gemma":0.0019100223,"teacher_disagreement_score":0.0071028015,"about_ca_system_score_codex":0.00044165464,"about_ca_system_score_gemma":0.000741004,"threshold_uncertainty_score":0.023761213},"labels":[],"label_agreement":null},{"id":"W4385262311","doi":"10.1080/14728222.2023.2240018","title":"Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategies","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; National Sanitarium Association","keywords":"Medicine; Obstructive sleep apnea; Dilator; Pharmacotherapy; Pharyngeal muscles; Intensive care medicine; Neuroscience; Bioinformatics; Airway; Anesthesia; Internal medicine; Psychology","score_opus":0.1982236052926008,"score_gpt":0.4225220442694087,"score_spread":0.2242984389768079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385262311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004001127,0.9546419,0.0018629172,0.035081428,0.0021923857,0.00006453185,0.00019245454,0.000082293845,0.005482033],"genre_scores_gemma":[0.0072646393,0.9688455,0.003751809,0.012758596,0.003434575,0.0002100582,0.00030870398,0.000023831137,0.0034022678],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999086,0.00033316712,0.00008500782,0.00012023402,0.00027754184,0.000098064884],"domain_scores_gemma":[0.99844617,0.0007030156,0.00021289152,0.000036189984,0.00047892373,0.0001227716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017243886,0.0008534819,0.0015177188,0.0010936393,0.0003873175,0.0021010912,0.0013014216,0.002470526,0.01150047],"category_scores_gemma":[0.0023539874,0.00025111256,0.0012670857,0.00065265724,0.0007357334,0.0021842166,0.001162982,0.004417055,0.0041473443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032683084,0.0001982696,0.0003438834,0.0183776,0.00024841036,0.00026219978,0.00010950687,0.0006356061,0.0018604046,0.019479748,0.14880995,0.8093475],"study_design_scores_gemma":[0.00025294238,0.0003659693,0.0008262482,0.01927613,0.00033030708,0.00056451216,0.00021912814,0.0009004634,0.0005291583,0.021926701,0.9547582,0.000050169718],"about_ca_topic_score_codex":0.0011084133,"about_ca_topic_score_gemma":0.0037206514,"teacher_disagreement_score":0.01150047,"about_ca_system_score_codex":0.0012582002,"about_ca_system_score_gemma":0.002503107,"threshold_uncertainty_score":0.03847295},"labels":[],"label_agreement":null},{"id":"W4386316190","doi":"10.1080/14728222.2023.2247559","title":"New drug targets for the treatment of gout arthritis: what’s new?","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Medicine; Disease; Repurposing; Gout; Drug repositioning; Drug; Clinical trial; Arthritis; Intensive care medicine; Population; Approved drug; Bioinformatics; Pharmacology; Immunology; Internal medicine; Biology","score_opus":0.11531728934831652,"score_gpt":0.39513972017679544,"score_spread":0.2798224308284789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386316190","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011292463,0.9964349,0.00013806792,0.0017409631,0.0005653495,0.000007794044,0.00003706827,0.000009370832,0.00095353473],"genre_scores_gemma":[0.0007219207,0.99704474,0.00018690663,0.00091464067,0.00043832196,0.000009403093,0.000038694085,0.0000018919876,0.00064349605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997682,0.00004882043,0.00002499823,0.000039827308,0.000089184054,0.00002900003],"domain_scores_gemma":[0.9996019,0.000176007,0.000051779385,0.000009614831,0.0001313255,0.00002931814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059480127,0.0005645657,0.0011273861,0.0012536484,0.00025160576,0.0011239526,0.00073527434,0.0013577025,0.00643838],"category_scores_gemma":[0.00086747296,0.00017180188,0.00067614956,0.0010513634,0.0003913221,0.0014607232,0.0004668781,0.0022199939,0.0022374943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010424756,0.000079532765,0.00011428366,0.02446597,0.00013711529,0.00020011341,0.0000709004,0.00030163795,0.0016665101,0.004708509,0.06075,0.90740114],"study_design_scores_gemma":[0.000041661337,0.00013164929,0.0004080752,0.007915707,0.00014965555,0.0006464229,0.00007421208,0.0001262047,0.00030518117,0.0025731546,0.9876106,0.000017585846],"about_ca_topic_score_codex":0.00092332,"about_ca_topic_score_gemma":0.002573688,"teacher_disagreement_score":0.00643838,"about_ca_system_score_codex":0.0005040219,"about_ca_system_score_gemma":0.0010625877,"threshold_uncertainty_score":0.021538496},"labels":[],"label_agreement":null},{"id":"W4399300458","doi":"10.1080/14728222.2024.2362675","title":"Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Candesartan; Losartan; Benzimidazole; Tetrazole; Medicine; Pharmacology; Renin–angiotensin system; Angiotensin II; Angiotensin II receptor antagonist; Receptor; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Angiotensin-converting enzyme 2; Coronavirus disease 2019 (COVID-19); Internal medicine; Chemistry; Blood pressure; Disease; Stereochemistry","score_opus":0.1325843056078143,"score_gpt":0.4454472802360098,"score_spread":0.3128629746281955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399300458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97656554,0.0054787565,0.01165536,0.00028222572,0.000043319866,0.00009393123,0.000539189,0.00025688813,0.0050847945],"genre_scores_gemma":[0.98244804,0.0023494698,0.012940527,0.00007730407,0.000020718706,0.000061814244,0.0008404155,0.000018148967,0.001243576],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999907,0.00001989196,0.000004569303,0.000016907561,0.00003188472,0.00001981558],"domain_scores_gemma":[0.9998863,0.00004517723,0.000027893679,0.0000054780116,0.000020311494,0.000014872897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003638838,0.0005926617,0.0010129426,0.00025191542,0.00019993586,0.0005813611,0.00054005894,0.00035724248,0.0018067318],"category_scores_gemma":[0.00036191457,0.00020247085,0.00077731605,0.00028140665,0.00014967677,0.00042055978,0.00019250593,0.00043784626,0.00025795994],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004270288,0.0031994418,0.012136406,0.0018273778,0.00060992345,0.0013001454,0.0001514022,0.68201673,0.19003224,0.009243926,0.0027386015,0.092473574],"study_design_scores_gemma":[0.00046523826,0.00464577,0.0019517784,0.000028374898,0.00028595605,0.00029651247,0.00009337781,0.9453586,0.041699596,0.0006517513,0.0044774828,0.000045649496],"about_ca_topic_score_codex":0.0020163304,"about_ca_topic_score_gemma":0.0030150355,"teacher_disagreement_score":0.0020163304,"about_ca_system_score_codex":0.00060447573,"about_ca_system_score_gemma":0.00045699434,"threshold_uncertainty_score":0.0060441494},"labels":[],"label_agreement":null},{"id":"W4409922316","doi":"10.1080/14728222.2025.2500424","title":"The sigma–1 receptor: a mechanistically–informed therapeutic target for antidepressants","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; University Health Network; Brain and Cognition Discovery Foundation; Queen's University","funders":"","keywords":"Sigma-1 receptor; Pharmacology; Receptor; Medicine; Chemistry; Bioinformatics; Internal medicine; Biology; Agonist","score_opus":0.04978324787557406,"score_gpt":0.39410660911828854,"score_spread":0.34432336124271445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409922316","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000088088134,0.9951944,0.00021794558,0.0019955381,0.0007153972,0.000006564831,0.000038904593,0.000015015157,0.0017282169],"genre_scores_gemma":[0.0007937953,0.9960471,0.00022899958,0.001078482,0.0005149268,0.000008178702,0.00006144015,0.000002348423,0.0012646576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998628,0.000029530805,0.000013269247,0.00002382029,0.00005356265,0.000017116108],"domain_scores_gemma":[0.99981934,0.000058381145,0.000027032253,0.0000055303344,0.000070401904,0.000019307106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041442277,0.0006287699,0.0008022296,0.00072863826,0.00018527679,0.00069038785,0.00070338,0.0012272998,0.0061343955],"category_scores_gemma":[0.00048469356,0.0001488084,0.00041594772,0.00061636884,0.00034219574,0.00092912815,0.00044153022,0.0022114012,0.003708544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010776832,0.000044802244,0.00008518163,0.014209617,0.00007256403,0.00019537227,0.000047043868,0.00036174947,0.0030488486,0.009130902,0.115103126,0.8575931],"study_design_scores_gemma":[0.00002319091,0.00008534508,0.00023949982,0.0033812916,0.000059609276,0.0005690033,0.00003748058,0.00009881148,0.00028211926,0.003448411,0.99176484,0.000010340329],"about_ca_topic_score_codex":0.0007541045,"about_ca_topic_score_gemma":0.0018337196,"teacher_disagreement_score":0.0061343955,"about_ca_system_score_codex":0.0006218872,"about_ca_system_score_gemma":0.00085958675,"threshold_uncertainty_score":0.020521581},"labels":[],"label_agreement":null},{"id":"W4413910481","doi":"10.1080/14728222.2025.2552324","title":"Role of serotonin in the neurobiology of attention-deficit/hyperactivity disorder: a systematic literature review","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Otsuka Pharmaceutical Development and Commercialization; Otsuka Pharmaceutical","keywords":"Attention deficit hyperactivity disorder; Neuroscience; Serotonin; Psychology; Attention deficit; Psychiatry; Medicine; Internal medicine","score_opus":0.038140994516687496,"score_gpt":0.3728871866859787,"score_spread":0.3347461921692912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413910481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033137662,0.9988932,0.00006267608,0.00021408283,0.00007950134,0.00008670111,0.00014156193,0.000003841727,0.00018707234],"genre_scores_gemma":[0.004533128,0.99462885,0.00020045905,0.00026603913,0.00005743369,0.000125166,0.000105756764,0.0000015578897,0.000081582875],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99747235,0.00078804384,0.0008517982,0.00023590818,0.0005298416,0.000121950645],"domain_scores_gemma":[0.9885938,0.008050227,0.0019776644,0.00013575608,0.0010911518,0.0001514548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041895127,0.0012174358,0.0048991833,0.0077854847,0.00049553544,0.0020286515,0.0014489002,0.0016873033,0.0055828155],"category_scores_gemma":[0.017199319,0.00065799407,0.003862672,0.008543559,0.0005965044,0.001752758,0.0010486136,0.0008971864,0.00048723182],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008609765,0.000012750494,0.0005959816,0.9413627,0.0033507315,0.00014613739,0.00013010428,0.000082863524,0.0001410948,0.00026896858,0.002354483,0.051468104],"study_design_scores_gemma":[0.000104300685,0.000113913826,0.00391783,0.93073404,0.037606988,0.0005734618,0.0002087782,0.000077303135,0.00012648253,0.0003403353,0.02617197,0.000024512627],"about_ca_topic_score_codex":0.008562762,"about_ca_topic_score_gemma":0.025046574,"teacher_disagreement_score":0.008562762,"about_ca_system_score_codex":0.0027923286,"about_ca_system_score_gemma":0.01108324,"threshold_uncertainty_score":0.022156477},"labels":[],"label_agreement":null},{"id":"W4417534740","doi":"10.1080/14728222.2025.2608031","title":"Harnessing mismatch repair deficiency for therapeutic targeting in cancers","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Rally Foundation; U.S. Department of Defense","keywords":"DNA mismatch repair; Immune system; Biomarker; Cancer; Tumor microenvironment; Genome instability; Cancer treatment; Microsatellite instability","score_opus":0.03535287086509377,"score_gpt":0.3513386484449475,"score_spread":0.31598577757985374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417534740","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063443244,0.94521743,0.00886243,0.021758404,0.0037853445,0.00009378964,0.0003246417,0.00027624704,0.013337489],"genre_scores_gemma":[0.06632731,0.901379,0.0055459486,0.011936138,0.0031500182,0.00012579774,0.00058748754,0.00005943557,0.010888772],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996557,0.000085368425,0.000020276371,0.000053949643,0.00013256374,0.0000521587],"domain_scores_gemma":[0.9996973,0.00010889688,0.0000591751,0.000013721088,0.00007862135,0.000042163363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065655337,0.0004119845,0.0006959341,0.00050984026,0.00020815144,0.0010921562,0.0005686553,0.001194548,0.0053088428],"category_scores_gemma":[0.0008028391,0.00014475662,0.00048097942,0.00026906555,0.00055560464,0.0008990446,0.0006409911,0.002099817,0.0022272607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036502763,0.00013999092,0.0009481786,0.008373746,0.0001986055,0.0009353378,0.00015837654,0.0013943916,0.0840213,0.02283891,0.12814687,0.7524792],"study_design_scores_gemma":[0.00009083485,0.0003767604,0.00091310864,0.0012646116,0.00011111927,0.0021409376,0.0000998232,0.0008697593,0.019298434,0.008702157,0.9660999,0.00003254412],"about_ca_topic_score_codex":0.0003985697,"about_ca_topic_score_gemma":0.0012350178,"teacher_disagreement_score":0.0053088428,"about_ca_system_score_codex":0.0007536357,"about_ca_system_score_gemma":0.0005434989,"threshold_uncertainty_score":0.0177598},"labels":[],"label_agreement":null}]}